{"id":325,"date":"2022-06-14T15:33:54","date_gmt":"2022-06-14T15:33:54","guid":{"rendered":"http:\/\/34.145.165.175\/?page_id=325"},"modified":"2022-06-14T18:16:53","modified_gmt":"2022-06-14T18:16:53","slug":"publications","status":"publish","type":"page","link":"https:\/\/tnl-mcgill.com\/?page_id=325","title":{"rendered":"Publications"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

2022<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  1. Nilsson, J, Ashton, NJ, Benedet, AL, Montoliu-Gaya, L, Gobom, J, Pascoal, TA\u00a0et al.<\/i>. Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease. Alzheimers Res Ther. 2022;14 (1):78. doi:\u00a010.1186\/s13195-022-01021-8<\/a>. PubMed\u00a0PMID:35659284<\/a>\u00a0.<\/li>
  2. Karikari, TK, Ashton, NJ, Brinkmalm, G, Brum, WS, Benedet, AL, Montoliu-Gaya, L\u00a0et al.<\/i>. Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility. Nat Rev Neurol. 2022; :. doi:\u00a010.1038\/s41582-022-00665-2<\/a>. PubMed\u00a0PMID:35585226<\/a>\u00a0.<\/li>
  3. Xie, K, Chen, Y, Chu, M, Cui, Y, Chen, Z, Zhang, J\u00a0et al.<\/i>. Specific structuro-metabolic pattern of thalamic subnuclei in fatal familial insomnia: A PET\/MRI imaging study. Neuroimage Clin. 2022;34 :103026. doi:\u00a010.1016\/j.nicl.2022.103026<\/a>. PubMed\u00a0PMID:35504222<\/a>\u00a0PubMed Central\u00a0PMC9065920<\/a>.<\/li>
  4. Chu, M, Xie, K, Zhang, J, Chen, Z, Ghorayeb, I, Rupprecht, S\u00a0et al.<\/i>. Proposal of new diagnostic criteria for fatal familial insomnia. J Neurol. 2022; :. doi:\u00a010.1007\/s00415-022-11135-6<\/a>. PubMed\u00a0PMID:35501502<\/a>\u00a0.<\/li>
  5. Bdair, H, Singleton, TA, Ross, K, Jolly, D, Kang, MS, Aliaga, A\u00a0et al.<\/i>. Radiosynthesis and\u00a0In Vivo<\/i>\u00a0Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors. ACS Chem Neurosci. 2022;13 (9):1382-1394. doi:\u00a010.1021\/acschemneuro.1c00678<\/a>. PubMed\u00a0PMID:35420022<\/a>\u00a0.<\/li>
  6. Liu, L, Chu, M, Nie, B, Liu, L, Xie, K, Cui, Y\u00a0et al.<\/i>. Reconfigured metabolism brain network in asymptomatic microtubule-associated protein tau mutation carriers: a graph theoretical analysis. Alzheimers Res Ther. 2022;14 (1):52. doi:\u00a010.1186\/s13195-022-01000-z<\/a>. PubMed\u00a0PMID:35410286<\/a>\u00a0PubMed Central\u00a0PMC8996677<\/a>.<\/li>
  7. Brum, WS, de Bastiani, MA, Bieger, A, Therriault, J, Ferrari-Souza, JP, Benedet, AL\u00a0et al.<\/i>. A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer’s disease. Alzheimers Dement (N Y). 2022;8 (1):e12270. doi:\u00a010.1002\/trc2.12270<\/a>. PubMed\u00a0PMID:35310530<\/a>\u00a0PubMed Central\u00a0PMC8918110<\/a>.<\/li>
  8. Hopewell, R, Jolly, D, Li, QY, Ross, K, Tsai, IH, Lacatus-Samoila, M\u00a0et al.<\/i>. High-yielding, automated radiosynthesis of [11<\/sup>\u00a0C]martinostat using [11<\/sup>\u00a0C]methyl triflate. J Labelled Comp Radiopharm. 2022;65 (6):167-173. doi:\u00a010.1002\/jlcr.3968<\/a>. PubMed\u00a0PMID:35218059<\/a>\u00a0.<\/li>
  9. Cassidy, CM, Therriault, J, Pascoal, TA, Cheung, V, Savard, M, Tuominen, L\u00a0et al.<\/i>. Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer’s disease. Neuropsychopharmacology. 2022;47 (5):1128-1136. doi:\u00a010.1038\/s41386-022-01293-6<\/a>. PubMed\u00a0PMID:35177805<\/a>\u00a0PubMed Central\u00a0PMC8938499<\/a>.<\/li>
  10. Ashton, NJ, Benedet, AL, Pascoal, TA, Karikari, TK, Lantero-Rodriguez, J, Brum, WS\u00a0et al.<\/i>. Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer’s disease. EBioMedicine. 2022;76 :103836. doi:\u00a010.1016\/j.ebiom.2022.103836<\/a>. PubMed\u00a0PMID:35158308<\/a>\u00a0PubMed Central\u00a0PMC8850760<\/a>.<\/li>
  11. Ziff, OJ, Ashton, NJ, Mehta, PR, Brown, R, Athauda, D, Heaney, J\u00a0et al.<\/i>. Amyloid processing in COVID-19-associated neurological syndromes. J Neurochem. 2022;161 (2):146-157. doi:\u00a010.1111\/jnc.15585<\/a>. PubMed\u00a0PMID:35137414<\/a>\u00a0PubMed Central\u00a0PMC9115071<\/a>.<\/li>
  12. Tissot, C, Therriault, J, Kunach, P, L Benedet, A, Pascoal, TA, Ashton, NJ\u00a0et al.<\/i>. Comparing tau status determined via plasma pTau181, pTau231 and [18<\/sup>F]MK6240 tau-PET. EBioMedicine. 2022;76 :103837. doi:\u00a010.1016\/j.ebiom.2022.103837<\/a>. PubMed\u00a0PMID:35134647<\/a>\u00a0PubMed Central\u00a0PMC8844756<\/a>.<\/li>
  13. Rocha, A, Bellaver, B, Souza, DG, Schu, G, Fontana, IC, Venturin, GT\u00a0et al.<\/i>. Clozapine induces astrocyte-dependent FDG-PET hypometabolism. Eur J Nucl Med Mol Imaging. 2022;49 (7):2251-2264. doi:\u00a010.1007\/s00259-022-05682-3<\/a>. PubMed\u00a0PMID:35122511<\/a>\u00a0.<\/li>
  14. Jansen, WJ, Janssen, O, Tijms, BM, Vos, SJB, Ossenkoppele, R, Visser, PJ\u00a0et al.<\/i>. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol. 2022;79 (3):228-243. doi:\u00a010.1001\/jamaneurol.2021.5216<\/a>. PubMed\u00a0PMID:35099509<\/a>\u00a0.<\/li>
  15. Savard, M, Pascoal, TA, Servaes, S, Dhollander, T, Iturria-Medina, Y, Kang, MS\u00a0et al.<\/i>. Impact of long- and short-range fibre depletion on the cognitive deficits of fronto-temporal dementia. Elife. 2022;11 :. doi:\u00a010.7554\/eLife.73510<\/a>. PubMed\u00a0PMID:35073256<\/a>\u00a0PubMed Central\u00a0PMC8824472<\/a>.<\/li>
  16. Terada, T, Therriault, J, Kang, MS, Savard, M, Pascoal, TA, Lussier, F\u00a0et al.<\/i>. Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer’s disease. Eur J Neurol. 2022;29 (5):1324-1334. doi:\u00a010.1111\/ene.15246<\/a>. PubMed\u00a0PMID:35007366<\/a>\u00a0.<\/li>
  17. Kwan, C, Kang, MS, Nuara, SG, Gourdon, JC, B\u00e9dard, D, Tardif, CL\u00a0et al.<\/i>. Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common Marmoset. Neuroscience. 2022;480 :143-154. doi:\u00a010.1016\/j.neuroscience.2021.11.009<\/a>. PubMed\u00a0PMID:34774970<\/a>\u00a0.<\/li>
  18. Gobom, J, Parnetti, L,\u00a0Rosa-Neto, P<\/strong>, Vyhnalek, M, Gauthier, S, Cataldi, S\u00a0et al.<\/i>. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. Clin Chem Lab Med. 2022;60 (2):207-219. doi:\u00a010.1515\/cclm-2021-0651<\/a>. PubMed\u00a0PMID:34773730<\/a>\u00a0.<\/li>
  19. Levy, JP, Bezgin, G, Savard, M, Pascoal, TA, Finger, E, Laforce, R\u00a0et al.<\/i>. 18F-MK-6240 tau-PET in genetic frontotemporal dementia. Brain. 2022;145 (5):1763-1772. doi:\u00a010.1093\/brain\/awab392<\/a>. PubMed\u00a0PMID:34664612<\/a>\u00a0.<\/li>
  20. Picard, C, Nilsson, N, Labont\u00e9, A, Auld, D,\u00a0Rosa-Neto, P<\/strong>, Alzheimer’s Disease Neuroimaging Initiative\u00a0et al.<\/i>. Apolipoprotein B is a novel marker for early tau pathology in Alzheimer’s disease. Alzheimers Dement. 2022;18 (5):875-887. doi:\u00a010.1002\/alz.12442<\/a>. PubMed\u00a0PMID:34590423<\/a>\u00a0.<\/li>
  21. Kang, MS, Shin, M, Ottoy, J, Aliaga, AA, Mathotaarachchi, S, Quispialaya, K\u00a0et al.<\/i>. Preclinical\u00a0in vivo<\/i><\/i>\u00a0longitudinal assessment of KG207-M as a disease-modifying Alzheimer’s disease therapeutic. J Cereb Blood Flow Metab. 2022;42 (5):788-801. doi:\u00a010.1177\/0271678X211035625<\/a>. PubMed\u00a0PMID:34378436<\/a>\u00a0PubMed Central\u00a0PMC9014686<\/a>.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    2021<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    1. Therriault, J, Pascoal, T, Gauthier, S,\u00a0Rosa-Neto, P<\/strong>. Author Response: Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex,\u00a0APOE<\/i>\u00a0\u03b54, and Cognitive Impairment. Neurology. 2021;97 (12):609. doi:\u00a010.1212\/WNL.0000000000012586<\/a>. PubMed\u00a0PMID:35100130<\/a>\u00a0.<\/li>
    2. Povala, G, Bellaver, B, De Bastiani, MA, Brum, WS, Ferreira, PCL, Bieger, A\u00a0et al.<\/i>. Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology. Cell Biosci. 2021;11 (1):204. doi:\u00a010.1186\/s13578-021-00712-3<\/a>. PubMed\u00a0PMID:34895338<\/a>\u00a0PubMed Central\u00a0PMC8665586<\/a>.<\/li>
    3. Janssen, O, Jansen, WJ, Vos, SJB, Boada, M, Parnetti, L, Gabryelewicz, T\u00a0et al.<\/i>. Characteristics of subjective cognitive decline associated with amyloid positivity. Alzheimers Dement. 2021; :. doi:\u00a010.1002\/alz.12512<\/a>. PubMed\u00a0PMID:34877782<\/a>\u00a0.<\/li>
    4. Lantero-Rodriguez, J, Snellman, A, Benedet, AL, Mil\u00e0-Alom\u00e0, M, Camporesi, E, Montoliu-Gaya, L\u00a0et al.<\/i>. P-tau235: a novel biomarker for staging preclinical Alzheimer’s disease. EMBO Mol Med. 2021;13 (12):e15098. doi:\u00a010.15252\/emmm.202115098<\/a>. PubMed\u00a0PMID:34725927<\/a>\u00a0PubMed Central\u00a0PMC8649868<\/a>.<\/li>
    5. Chu, M, Liu, L, Wang, J, Liu, L, Kong, Y, Jing, D\u00a0et al.<\/i>. Investigating the Roles of Anterior Cingulate in Behavioral Variant Frontotemporal Dementia: A PET\/MRI Study. J Alzheimers Dis. 2021;84 (4):1771-1779. doi:\u00a010.3233\/JAD-215127<\/a>. PubMed\u00a0PMID:34719498<\/a>\u00a0PubMed Central\u00a0PMC8764589<\/a>.<\/li>
    6. Benedet, AL, Mil\u00e0-Alom\u00e0, M, Vrillon, A, Ashton, NJ, Pascoal, TA, Lussier, F\u00a0et al.<\/i>. Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum. JAMA Neurol. 2021;78 (12):1471-1483. doi:\u00a010.1001\/jamaneurol.2021.3671<\/a>. PubMed\u00a0PMID:34661615<\/a>\u00a0PubMed Central\u00a0PMC8524356<\/a>.<\/li>
    7. Pascoal, TA, Benedet, AL, Ashton, NJ, Kang, MS, Therriault, J, Chamoun, M\u00a0et al.<\/i>. Publisher Correction: Microglial activation and tau propagate jointly across Braak stages. Nat Med. 2021;27 (11):2048-2049. doi:\u00a010.1038\/s41591-021-01568-3<\/a>. PubMed\u00a0PMID:34654920<\/a>\u00a0.<\/li>
    8. Legault-Denis, C, Aghourian, M, Soucy, JP,\u00a0Rosa-Neto, P<\/strong>, Dagher, A, Aumont, E\u00a0et al.<\/i>. Normal cognition in Parkinson’s disease may involve hippocampal cholinergic compensation: An exploratory PET imaging study with [18<\/sup>F]-FEOBV. Parkinsonism Relat Disord. 2021;91 :162-166. doi:\u00a010.1016\/j.parkreldis.2021.09.018<\/a>. PubMed\u00a0PMID:34628195<\/a>\u00a0.<\/li>
    9. Therriault, J, Pascoal, TA, Sefranek, M, Mathotaarachchi, S, Benedet, AL, Chamoun, M\u00a0et al.<\/i>. Amyloid-dependent and amyloid-independent effects of Tau in individuals without dementia. Ann Clin Transl Neurol. 2021;8 (10):2083-2092. doi:\u00a010.1002\/acn3.51457<\/a>. PubMed\u00a0PMID:34617688<\/a>\u00a0PubMed Central\u00a0PMC8528464<\/a>.<\/li>
    10. Gauthier, S,\u00a0Rosa-Neto, P<\/strong>. Commentary: The US Expert Panel on the Appropriate Use Recommendations of Aducanumab in Clinical Practice. J Prev Alzheimers Dis. 2021;8 (4):411. doi:\u00a010.14283\/jpad.2021.44<\/a>. PubMed\u00a0PMID:34585213<\/a>\u00a0.<\/li>
    11. Lindberg, A, Mossine, AV, Aliaga, A, Hopewell, R, Massarweh, G,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Preliminary Evaluations of [11<\/sup>C]Verubulin: Implications for Microtubule Imaging With PET. Front Neurosci. 2021;15 :725873. doi:\u00a010.3389\/fnins.2021.725873<\/a>. PubMed\u00a0PMID:34566568<\/a>\u00a0PubMed Central\u00a0PMC8456034<\/a>.<\/li>
    12. Kanel, P, Bedard, MA, Aghourian, M,\u00a0Rosa-Neto, P<\/strong>, Soucy, JP, Albin, RL\u00a0et al.<\/i>. Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views. Curr Neurol Neurosci Rep. 2021;21 (10):52. doi:\u00a010.1007\/s11910-021-01140-z<\/a>. PubMed\u00a0PMID:34545424<\/a>\u00a0PubMed Central\u00a0PMC9020458<\/a>.<\/li>
    13. Pascoal, TA, Benedet, AL, Tudorascu, DL, Therriault, J, Mathotaarachchi, S, Savard, M\u00a0et al.<\/i>. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages. Brain. 2021;144 (11):3517-3528. doi:\u00a010.1093\/brain\/awab248<\/a>. PubMed\u00a0PMID:34515754<\/a>\u00a0PubMed Central\u00a0PMC8677534<\/a>.<\/li>
    14. Aghourian, M, Aumont, \u00c9, Grothe, MJ, Soucy, JP,\u00a0Rosa-Neto, P<\/strong>, Bedard, MA\u00a0et al.<\/i>. FEOBV-PET to quantify cortical cholinergic denervation in AD: Relationship to basal forebrain volumetry. J Neuroimaging. 2021;31 (6):1077-1081. doi:\u00a010.1111\/jon.12921<\/a>. PubMed\u00a0PMID:34462992<\/a>\u00a0.<\/li>
    15. Pascoal, TA, Benedet, AL, Ashton, NJ, Kang, MS, Therriault, J, Chamoun, M\u00a0et al.<\/i>. Microglial activation and tau propagate jointly across Braak stages. Nat Med. 2021;27 (9):1592-1599. doi:\u00a010.1038\/s41591-021-01456-w<\/a>. PubMed\u00a0PMID:34446931<\/a>\u00a0.<\/li>
    16. Paterson, RW, Benjamin, LA, Mehta, PR, Brown, RL, Athauda, D, Ashton, NJ\u00a0et al.<\/i>. Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes. Brain Commun. 2021;3 (3):fcab099. doi:\u00a010.1093\/braincomms\/fcab099<\/a>. PubMed\u00a0PMID:34396099<\/a>\u00a0PubMed Central\u00a0PMC8194666<\/a>.<\/li>
    17. Boyle, AJ, Gaudet, VC, Black, SE, Vasdev, N,\u00a0Rosa-Neto, P<\/strong>, Zukotynski, KA\u00a0et al.<\/i>. Artificial intelligence for molecular neuroimaging. Ann Transl Med. 2021;9 (9):822. doi:\u00a010.21037\/atm-20-6220<\/a>. PubMed\u00a0PMID:34268435<\/a>\u00a0PubMed Central\u00a0PMC8246223<\/a>.<\/li>
    18. Therriault, J, Benedet, AL, Pascoal, TA, Lussier, FZ, Tissot, C, Karikari, TK\u00a0et al.<\/i>. Association of plasma P-tau181 with memory decline in non-demented adults. Brain Commun. 2021;3 (3):fcab136. doi:\u00a010.1093\/braincomms\/fcab136<\/a>. PubMed\u00a0PMID:34222875<\/a>\u00a0PubMed Central\u00a0PMC8249102<\/a>.<\/li>
    19. Tremblay-Mercier, J, Madjar, C, Das, S, Pichet Binette, A, Dyke, SOM, \u00c9tienne, P\u00a0et al.<\/i>. Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer’s disease. Neuroimage Clin. 2021;31 :102733. doi:\u00a010.1016\/j.nicl.2021.102733<\/a>. PubMed\u00a0PMID:34192666<\/a>\u00a0PubMed Central\u00a0PMC8254111<\/a>.<\/li>
    20. Wang, YT, Pascoal, TA, Therriault, J, Kang, MS, Benedet, AL, Savard, M\u00a0et al.<\/i>. Interactive rather than independent effect of\u00a0APOE<\/i>\u00a0and sex potentiates tau deposition in women. Brain Commun. 2021;3 (2):fcab126. doi:\u00a010.1093\/braincomms\/fcab126<\/a>. PubMed\u00a0PMID:34189460<\/a>\u00a0PubMed Central\u00a0PMC8226193<\/a>.<\/li>
    21. Ashton, NJ, Janelidze, S, Al Khleifat, A, Leuzy, A, van der Ende, EL, Karikari, TK\u00a0et al.<\/i>. A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun. 2021;12 (1):3400. doi:\u00a010.1038\/s41467-021-23620-z<\/a>. PubMed\u00a0PMID:34099648<\/a>\u00a0PubMed Central\u00a0PMC8185001<\/a>.<\/li>
    22. Lam, J, DuBois, JM, Rowley, J, Rousset, OG, Gonz\u00e1lez-Ot\u00e1rula, KA, Soucy, JP\u00a0et al.<\/i>. In vivo hippocampal cornu ammonis 1-3 glutamatergic abnormalities are associated with temporal lobe epilepsy surgery outcomes. Epilepsia. 2021;62 (7):1559-1568. doi:\u00a010.1111\/epi.16952<\/a>. PubMed\u00a0PMID:34060082<\/a>\u00a0.<\/li>
    23. Leuzy, A, Pascoal, TA, Strandberg, O, Insel, P, Smith, R, Mattsson-Carlgren, N\u00a0et al.<\/i>. A multicenter comparison of [18<\/sup>F]flortaucipir, [18<\/sup>F]RO948, and [18<\/sup>F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis. Eur J Nucl Med Mol Imaging. 2021;48 (7):2295-2305. doi:\u00a010.1007\/s00259-021-05401-4<\/a>. PubMed\u00a0PMID:34041562<\/a>\u00a0PubMed Central\u00a0PMC8175317<\/a>.<\/li>
    24. Ng, KP, Cheng, GH, Yatawara, C,\u00a0Rosa-Neto, P<\/strong>, Gauthier, S, Kandiah, N\u00a0et al.<\/i>. Baseline Neurodegeneration Influences the Longitudinal Effects of Tau on Cognition. J Alzheimers Dis. 2021;82 (1):159-167. doi:\u00a010.3233\/JAD-201425<\/a>. PubMed\u00a0PMID:33998536<\/a>\u00a0.<\/li>
    25. Lussier, FZ, Benedet, AL, Therriault, J, Pascoal, TA, Tissot, C, Chamoun, M\u00a0et al.<\/i>. Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals. Brain Commun. 2021;3 (2):fcab073. doi:\u00a010.1093\/braincomms\/fcab073<\/a>. PubMed\u00a0PMID:33959711<\/a>\u00a0PubMed Central\u00a0PMC8088291<\/a>.<\/li>
    26. Bellaver, B, Ferrari-Souza, JP, Uglione da Ros, L, Carter, SF, Rodriguez-Vieitez, E, Nordberg, A\u00a0et al.<\/i>. Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis. Neurology. 2021; :. doi:\u00a010.1212\/WNL.0000000000012109<\/a>. PubMed\u00a0PMID:33952650<\/a>\u00a0.<\/li>
    27. Lyra E Silva, NM, Gon\u00e7alves, RA, Pascoal, TA, Lima-Filho, RAS, Resende, EPF, Vieira, ELM\u00a0et al.<\/i>. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease. Transl Psychiatry. 2021;11 (1):251. doi:\u00a010.1038\/s41398-021-01349-z<\/a>. PubMed\u00a0PMID:33911072<\/a>\u00a0PubMed Central\u00a0PMC8080782<\/a>.<\/li>
    28. Terada, T, Therriault, J, Kang, MSP, Savard, M, Pascoal, TA, Lussier, F\u00a0et al.<\/i>. Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer’s disease. Mol Neurodegener. 2021;16 (1):28. doi:\u00a010.1186\/s13024-021-00448-1<\/a>. PubMed\u00a0PMID:33902654<\/a>\u00a0PubMed Central\u00a0PMC8074456<\/a>.<\/li>
    29. Tissot, C, Therriault, J, Pascoal, TA, Chamoun, M, Lussier, FZ, Savard, M\u00a0et al.<\/i>. Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer’s disease. Alzheimers Dement (N Y). 2021;7 (1):e12154. doi:\u00a010.1002\/trc2.12154<\/a>. PubMed\u00a0PMID:33816761<\/a>\u00a0PubMed Central\u00a0PMC8012244<\/a>.<\/li>
    30. Ng, KP, Chiew, H,\u00a0Rosa-Neto, P<\/strong>, Kandiah, N, Ismail, Z, Gauthier, S\u00a0et al.<\/i>. Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals. Transl Neurodegener. 2021;10 (1):11. doi:\u00a010.1186\/s40035-021-00236-3<\/a>. PubMed\u00a0PMID:33789730<\/a>\u00a0PubMed Central\u00a0PMC8011383<\/a>.<\/li>
    31. Tissot, C, L Benedet, A, Therriault, J, Pascoal, TA, Lussier, FZ, Saha-Chaudhuri, P\u00a0et al.<\/i>. Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer’s disease. Alzheimers Res Ther. 2021;13 (1):69. doi:\u00a010.1186\/s13195-021-00802-x<\/a>. PubMed\u00a0PMID:33781319<\/a>\u00a0PubMed Central\u00a0PMC8008680<\/a>.<\/li>
    32. Ashton, NJ, Pascoal, TA, Karikari, TK, Benedet, AL, Lantero-Rodriguez, J, Brinkmalm, G\u00a0et al.<\/i>. Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology. Acta Neuropathol. 2021;141 (5):709-724. doi:\u00a010.1007\/s00401-021-02275-6<\/a>. PubMed\u00a0PMID:33585983<\/a>\u00a0PubMed Central\u00a0PMC8043944<\/a>.<\/li>
    33. Simr\u00e9n, J, Leuzy, A, Karikari, TK, Hye, A, Benedet, AL, Lantero-Rodriguez, J\u00a0et al.<\/i>. The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer’s disease. Alzheimers Dement. 2021;17 (7):1145-1156. doi:\u00a010.1002\/alz.12283<\/a>. PubMed\u00a0PMID:33491853<\/a>\u00a0PubMed Central\u00a0PMC8359457<\/a>.<\/li>
    34. Therriault, J, Pascoal, TA, Benedet, AL, Tissot, C, Savard, M, Chamoun, M\u00a0et al.<\/i>. Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex,\u00a0APOE<\/i>\u00a0\u03b54, and Cognitive Impairment. Neurology. 2021;96 (7):e975-e985. doi:\u00a010.1212\/WNL.0000000000011416<\/a>. PubMed\u00a0PMID:33443136<\/a>\u00a0PubMed Central\u00a0PMC8055338<\/a>.<\/li>
    35. DuBois, JM, Mathotaarachchi, S, Rousset, OG, Sziklas, V, Sepulcre, J, Guiot, MC\u00a0et al.<\/i>. Large-scale mGluR5 network abnormalities linked to epilepsy duration in focal cortical dysplasia. Neuroimage Clin. 2021;29 :102552. doi:\u00a010.1016\/j.nicl.2020.102552<\/a>. PubMed\u00a0PMID:33401137<\/a>\u00a0PubMed Central\u00a0PMC7787952<\/a>.<\/li>
    36. Ng, KP, Pascoal, TA, Mathotaarachchi, S, Chan, YH, Jiang, L, Therriault, J\u00a0et al.<\/i>. Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease. Transl Neurodegener. 2021;10 (1):1. doi:\u00a010.1186\/s40035-020-00225-y<\/a>. PubMed\u00a0PMID:33390174<\/a>\u00a0PubMed Central\u00a0PMC7780680<\/a>.<\/li>
    37. Karikari, TK, Benedet, AL, Ashton, NJ, Lantero Rodriguez, J, Snellman, A, Su\u00e1rez-Calvet, M\u00a0et al.<\/i>. Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative. Mol Psychiatry. 2021;26 (2):429-442. doi:\u00a010.1038\/s41380-020-00923-z<\/a>. PubMed\u00a0PMID:33106600<\/a>\u00a0.<\/li>
    38. Therriault, J, Pascoal, TA, Savard, M, Benedet, AL, Chamoun, M, Tissot, C\u00a0et al.<\/i>. Topographic Distribution of Amyloid-\u03b2, Tau, and Atrophy in Patients With Behavioral\/Dysexecutive Alzheimer Disease. Neurology. 2021;96 (1):e81-e92. doi:\u00a010.1212\/WNL.0000000000011081<\/a>. PubMed\u00a0PMID:33093220<\/a>\u00a0PubMed Central\u00a0PMC7884976<\/a>.<\/li>
    39. Cristini, J, Weiss, M, De Las Heras, B, Medina-Rinc\u00f3n, A, Dagher, A, Postuma, RB\u00a0et al.<\/i>. The effects of exercise on sleep quality in persons with Parkinson’s disease: A systematic review with meta-analysis. Sleep Med Rev. 2021;55 :101384. doi:\u00a010.1016\/j.smrv.2020.101384<\/a>. PubMed\u00a0PMID:32987321<\/a>\u00a0.<\/li>
    40. Zukotynski, K, Gaudet, V, Uribe, CF, Mathotaarachchi, S, Smith, KC,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Machine Learning in Nuclear Medicine: Part 2-Neural Networks and Clinical Aspects. J Nucl Med. 2021;62 (1):22-29. doi:\u00a010.2967\/jnumed.119.231837<\/a>. PubMed\u00a0PMID:32978286<\/a>\u00a0.<\/li>
    41. van den Brink, SEM, El Amrani, L, Therriault, J, Gauthier, S,\u00a0Rosa-Neto, P<\/strong>, Vitali, P\u00a0et al.<\/i>. Diagnostic Impact of Cerebrospinal Fluid Biomarkers in Atypical Dementias in Canada. Can J Neurol Sci. 2021;48 (3):312-320. doi:\u00a010.1017\/cjn.2020.196<\/a>. PubMed\u00a0PMID:32892784<\/a>\u00a0.<\/li>
    42. Therriault, J, Benedet, AL, Pascoal, TA, Savard, M, Ashton, NJ, Chamoun, M\u00a0et al.<\/i>. Determining Amyloid-\u03b2 Positivity Using\u00a018<\/sup>F-AZD4694 PET Imaging. J Nucl Med. 2021;62 (2):247-252. doi:\u00a010.2967\/jnumed.120.245209<\/a>. PubMed\u00a0PMID:32737243<\/a>\u00a0.<\/li>
    43. Kang, MS, Aliaga, AA, Shin, M, Mathotaarachchi, S, Benedet, AL, Pascoal, TA\u00a0et al.<\/i>. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease. Mol Psychiatry. 2021;26 (10):5989-6001. doi:\u00a010.1038\/s41380-020-0818-1<\/a>. PubMed\u00a0PMID:32591633<\/a>\u00a0PubMed Central\u00a0PMC8758474<\/a>.<\/li>
    44. Smart, K, Nagano-Saito, A, Milella, MS, Sakae, DY, Favier, M, Vigneault, E\u00a0et al.<\/i>. Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humans. J Psychiatry Neurosci. 2021;46 (1):E1-E13. doi:\u00a010.1503\/jpn.190162<\/a>. PubMed\u00a0PMID:32559027<\/a>\u00a0PubMed Central\u00a0PMC7955855<\/a>.<\/li>
    45. Therriault, J, Benedet, AL, Pascoal, TA, Mathotaarachchi, S, Savard, M, Chamoun, M\u00a0et al.<\/i>. APOE\u03b54 potentiates the relationship between amyloid-\u03b2 and tau pathologies. Mol Psychiatry. 2021;26 (10):5977-5988. doi:\u00a010.1038\/s41380-020-0688-6<\/a>. PubMed\u00a0PMID:32161362<\/a>\u00a0PubMed Central\u00a0PMC8758492<\/a>.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t

      2020<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t
      1. Brisson, M, Brodeur, C, L\u00e9tourneau-Guillon, L, Masellis, M, Stoessl, J, Tamm, A\u00a0et al.<\/i>. CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment. Alzheimers Dement (N Y). 2020;6 (1):e12098. doi:\u00a010.1002\/trc2.12098<\/a>. PubMed\u00a0PMID:33532543<\/a>\u00a0PubMed Central\u00a0PMC7821956<\/a>.<\/li>
      2. Ng, KP, Chiew, HJ, Hameed, S, Ting, SKS, Ng, A, Soo, SA\u00a0et al.<\/i>. Frontotemporal dementia and COVID-19: Hypothesis generation and roadmap for future research. Alzheimers Dement (N Y). 2020;6 (1):e12085. doi:\u00a010.1002\/trc2.12085<\/a>. PubMed\u00a0PMID:33490361<\/a>\u00a0PubMed Central\u00a0PMC7810128<\/a>.<\/li>
      3. Tian Hui Kwan, A, Arfaie, S, Therriault, J,\u00a0Rosa-Neto, P<\/strong>, Gauthier, S. Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials. Dement Geriatr Cogn Disord. 2020;49 (4):334-348. doi:\u00a010.1159\/000511506<\/a>. PubMed\u00a0PMID:33321511<\/a>\u00a0.<\/li>
      4. Paquin, V, Therriault, J, Pascoal, TA,\u00a0Rosa-Neto, P<\/strong>, Gauthier, S. Frontal Variant of Alzheimer Disease Differentiated From Frontotemporal Dementia Using in Vivo Amyloid and Tau Imaging. Cogn Behav Neurol. 2020;33 (4):288-293. doi:\u00a010.1097\/WNN.0000000000000251<\/a>. PubMed\u00a0PMID:33264158<\/a>\u00a0.<\/li>
      5. Benedet, AL, Leuzy, A, Pascoal, TA, Ashton, NJ, Mathotaarachchi, S, Savard, M\u00a0et al.<\/i>. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer’s disease. Brain. 2020;143 (12):3793-3804. doi:\u00a010.1093\/brain\/awaa342<\/a>. PubMed\u00a0PMID:33210117<\/a>\u00a0PubMed Central\u00a0PMC7805809<\/a>.<\/li>
      6. Gauthier, S, Therriault, J, Pascoal, T,\u00a0Rosa-Neto, P<\/strong>. Impact of p-tau181 and p-tau217 levels on enrollment for randomized clinical trials and future use of anti-amyloid and anti-tau drugs. Expert Rev Neurother. 2020;20 (12):1211-1213. doi:\u00a010.1080\/14737175.2020.1841637<\/a>. PubMed\u00a0PMID:33094676<\/a>\u00a0.<\/li>
      7. Gauthier, S, Chertkow, H, Theriault, J, Chayer, C, M\u00e9nard, MC, Lacombe, G\u00a0et al.<\/i>. CCCDTD5: research diagnostic criteria for Alzheimer’s Disease. Alzheimers Dement (N Y). 2020;6 (1):e12036. doi:\u00a010.1002\/trc2.12036<\/a>. PubMed\u00a0PMID:32864413<\/a>\u00a0PubMed Central\u00a0PMC7446944<\/a>.<\/li>
      8. Ismail, Z, Black, SE, Camicioli, R, Chertkow, H, Herrmann, N, Laforce, R Jr\u00a0et al.<\/i>. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Alzheimers Dement. 2020;16 (8):1182-1195. doi:\u00a010.1002\/alz.12105<\/a>. PubMed\u00a0PMID:32725777<\/a>\u00a0PubMed Central\u00a0PMC7984031<\/a>.<\/li>
      9. Pascoal, TA, Therriault, J, Benedet, AL, Savard, M, Lussier, FZ, Chamoun, M\u00a0et al.<\/i>. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Brain. 2020;143 (9):2818-2830. doi:\u00a010.1093\/brain\/awaa180<\/a>. PubMed\u00a0PMID:32671408<\/a>\u00a0.<\/li>
      10. Pascoal, TA, Therriault, J, Mathotaarachchi, S, Kang, MS, Shin, M, Benedet, AL\u00a0et al.<\/i>. Topographical distribution of A\u03b2 predicts progression to dementia in A\u03b2 positive mild cognitive impairment. Alzheimers Dement (Amst). 2020;12 (1):e12037. doi:\u00a010.1002\/dad2.12037<\/a>. PubMed\u00a0PMID:32582834<\/a>\u00a0PubMed Central\u00a0PMC7306519<\/a>.<\/li>
      11. Sheynin, Y,\u00a0Rosa-Neto, P<\/strong>, Hess, RF, Vaucher, E. Cholinergic Modulation of Binocular Vision. J Neurosci. 2020;40 (27):5208-5213. doi:\u00a010.1523\/JNEUROSCI.2484-19.2020<\/a>. PubMed\u00a0PMID:32457075<\/a>\u00a0PubMed Central\u00a0PMC7329301<\/a>.<\/li>
      12. Karikari, TK, Pascoal, TA, Ashton, NJ, Janelidze, S, Benedet, AL, Rodriguez, JL\u00a0et al.<\/i>. Blood phosphorylated tau 181 as a biomarker for Alzheimer’s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19 (5):422-433. doi:\u00a010.1016\/S1474-4422(20)30071-5<\/a>. PubMed\u00a0PMID:32333900<\/a>\u00a0.<\/li>
      13. Knudsen, GM, Ganz, M, Appelhoff, S, Boellaard, R, Bormans, G, Carson, RE\u00a0et al.<\/i>. Guidelines for the content and format of PET brain data in publications and archives: A consensus paper. J Cereb Blood Flow Metab. 2020;40 (8):1576-1585. doi:\u00a010.1177\/0271678X20905433<\/a>. PubMed\u00a0PMID:32065076<\/a>\u00a0PubMed Central\u00a0PMC7370374<\/a>.<\/li>
      14. Pichet Binette, A, Gonneaud, J, Vogel, JW, La Joie, R,\u00a0Rosa-Neto, P<\/strong>, Collins, DL\u00a0et al.<\/i>. Morphometric network differences in ageing versus Alzheimer’s disease dementia. Brain. 2020;143 (2):635-649. doi:\u00a010.1093\/brain\/awz414<\/a>. PubMed\u00a0PMID:32040564<\/a>\u00a0PubMed Central\u00a0PMC7009528<\/a>.<\/li>
      15. K\u00f6be, T, Gonneaud, J, Pichet Binette, A, Meyer, PF, McSweeney, M,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Association of Vascular Risk Factors With \u03b2-Amyloid Peptide and Tau Burdens in Cognitively Unimpaired Individuals and Its Interaction With Vascular Medication Use. JAMA Netw Open. 2020;3 (2):e1920780. doi:\u00a010.1001\/jamanetworkopen.2019.20780<\/a>. PubMed\u00a0PMID:32031648<\/a>\u00a0.<\/li>
      16. McSweeney, M, Pichet Binette, A, Meyer, PF, Gonneaud, J, Bedetti, C, Ozlen, H\u00a0et al.<\/i>. Intermediate flortaucipir uptake is associated with A\u03b2-PET and CSF tau in asymptomatic adults. Neurology. 2020;94 (11):e1190-e1200. doi:\u00a010.1212\/WNL.0000000000008905<\/a>. PubMed\u00a0PMID:32015176<\/a>\u00a0.<\/li>
      17. Dehghani, M, Zhang, S, Kumaragamage, C,\u00a0Rosa-Neto, P<\/strong>, Near, J. Dynamic\u00a01<\/sup>\u00a0H-MRS for detection of\u00a013<\/sup>\u00a0C-labeled glucose metabolism in the human brain at 3T. Magn Reson Med. 2020;84 (3):1140-1151. doi:\u00a010.1002\/mrm.28188<\/a>. PubMed\u00a0PMID:32003052<\/a>\u00a0.<\/li>
      18. Singleton, TA, Bdair, H, Bailey, JJ, Choi, S, Aliaga, A,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Efficient radiosynthesis and preclinical evaluation of [18<\/sup>\u00a0F]FOMPyD as a positron emission tomography tracer candidate for TrkB\/C receptor imaging. J Labelled Comp Radiopharm. 2020;63 (3):144-150. doi:\u00a010.1002\/jlcr.3827<\/a>. PubMed\u00a0PMID:31919878<\/a>\u00a0.<\/li>
      19. Lussier, FZ, Pascoal, TA, Chamoun, M, Therriault, J, Tissot, C, Savard, M\u00a0et al.<\/i>. Mild behavioral impairment is associated with \u03b2-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals. Alzheimers Dement. 2020;16 (1):192-199. doi:\u00a010.1002\/alz.12007<\/a>. PubMed\u00a0PMID:31914223<\/a>\u00a0PubMed Central\u00a0PMC7041633<\/a>.<\/li>
      20. Therriault, J, Benedet, AL, Pascoal, TA, Mathotaarachchi, S, Chamoun, M, Savard, M\u00a0et al.<\/i>. Association of Apolipoprotein E \u03b54 With Medial Temporal Tau Independent of Amyloid-\u03b2. JAMA Neurol. 2020;77 (4):470-479. doi:\u00a010.1001\/jamaneurol.2019.4421<\/a>. PubMed\u00a0PMID:31860000<\/a>\u00a0PubMed Central\u00a0PMC6990684<\/a>.<\/li>
      21. Ng, KP, Richard-Devantoy, S, Bertrand, JA, Jiang, L, Pascoal, TA, Mathotaarachchi, S\u00a0et al.<\/i>. Suicidal ideation is common in autosomal dominant Alzheimer’s disease at-risk persons. Int J Geriatr Psychiatry. 2020;35 (1):60-68. doi:\u00a010.1002\/gps.5215<\/a>. PubMed\u00a0PMID:31642105<\/a>\u00a0PubMed Central\u00a0PMC7232741<\/a>.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t

        2019<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        1. Cisneros-Franco, JM, Voss, P, Kang, MS, Thomas, ME, C\u00f4t\u00e9, J, Ross, K\u00a0et al.<\/i>. PET Imaging of Perceptual Learning-Induced Changes in the Aged Rodent Cholinergic System. Front Neurosci. 2019;13 :1438. doi:\u00a010.3389\/fnins.2019.01438<\/a>. PubMed\u00a0PMID:32038142<\/a>\u00a0PubMed Central\u00a0PMC6985428<\/a>.<\/li>
        2. Ng, KP, Chiew, HJ,\u00a0Rosa-Neto, P<\/strong>, Kandiah, N, Ismail, Z, Gauthier, S\u00a0et al.<\/i>. Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia. Front Pharmacol. 2019;10 :1398. doi:\u00a010.3389\/fphar.2019.01398<\/a>. PubMed\u00a0PMID:31824321<\/a>\u00a0PubMed Central\u00a0PMC6882863<\/a>.<\/li>
        3. Ng, KP, Therriault, J, Kang, MS, Struyfs, H, Pascoal, TA, Mathotaarachchi, S\u00a0et al.<\/i>. Rasagiline, a monoamine oxidase B inhibitor, reduces\u00a0in vivo<\/i>\u00a0[18<\/sup>F]THK5351 uptake in progressive supranuclear palsy. Neuroimage Clin. 2019;24 :102091. doi:\u00a010.1016\/j.nicl.2019.102091<\/a>. PubMed\u00a0PMID:31795034<\/a>\u00a0PubMed Central\u00a0PMC6889764<\/a>.<\/li>
        4. Sharafi, SM, Sylvestre, JP, Chevrefils, C, Soucy, JP, Beaulieu, S, Pascoal, TA\u00a0et al.<\/i>. Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images. Alzheimers Dement (N Y). 2019;5 :610-617. doi:\u00a010.1016\/j.trci.2019.09.006<\/a>. PubMed\u00a0PMID:31650017<\/a>\u00a0PubMed Central\u00a0PMC6804547<\/a>.<\/li>
        5. Hadoux, X, Hui, F, Lim, JKH, Masters, CL, P\u00e9bay, A, Chevalier, S\u00a0et al.<\/i>. Non-invasive\u00a0in vivo<\/i>\u00a0hyperspectral imaging of the retina for potential biomarker use in Alzheimer’s disease. Nat Commun. 2019;10 (1):4227. doi:\u00a010.1038\/s41467-019-12242-1<\/a>. PubMed\u00a0PMID:31530809<\/a>\u00a0PubMed Central\u00a0PMC6748929<\/a>.<\/li>
        6. Shin, J, Rowley, J, Chowdhury, R, Jolicoeur, P, Klein, D, Grova, C\u00a0et al.<\/i>. Inferior Longitudinal Fasciculus’ Role in Visual Processing and Language Comprehension: A Combined MEG-DTI Study. Front Neurosci. 2019;13 :875. doi:\u00a010.3389\/fnins.2019.00875<\/a>. PubMed\u00a0PMID:31507359<\/a>\u00a0PubMed Central\u00a0PMC6716060<\/a>.<\/li>
        7. Ryu, JC, Zimmer, ER,\u00a0Rosa-Neto, P<\/strong>, Yoon, SO. Consequences of Metabolic Disruption in Alzheimer’s Disease Pathology. Neurotherapeutics. 2019;16 (3):600-610. doi:\u00a010.1007\/s13311-019-00755-y<\/a>. PubMed\u00a0PMID:31270743<\/a>\u00a0PubMed Central\u00a0PMC6694332<\/a>.<\/li>
        8. Cui, Y, Dai, S, Miao, Z, Zhong, Y, Liu, Y, Liu, L\u00a0et al.<\/i>. Reliability and Validity of the Chinese Version of the Mild Behavioral Impairment Checklist for Screening for Alzheimer’s Disease. J Alzheimers Dis. 2019;70 (3):747-756. doi:\u00a010.3233\/JAD-190113<\/a>. PubMed\u00a0PMID:31256131<\/a>\u00a0.<\/li>
        9. Therriault, J, Wang, S, Mathotaarachchi, S, Pascoal, TA, Parent, M, Beaudry, T\u00a0et al.<\/i>. Rostral-Caudal Hippocampal Functional Convergence Is Reduced Across the Alzheimer’s Disease Spectrum. Mol Neurobiol. 2019;56 (12):8336-8344. doi:\u00a010.1007\/s12035-019-01671-0<\/a>. PubMed\u00a0PMID:31230260<\/a>\u00a0.<\/li>
        10. Meyer, PF, Labont\u00e9, A,\u00a0Rosa-Neto, P<\/strong>, Poirier, J, Breitner, JCS, PREVENT\u2010AD Research Group\u00a0et al.<\/i>. No apparent effect of naproxen on CSF markers of innate immune activation. Ann Clin Transl Neurol. 2019;6 (6):1127-1133. doi:\u00a010.1002\/acn3.788<\/a>. PubMed\u00a0PMID:31211178<\/a>\u00a0PubMed Central\u00a0PMC6562029<\/a>.<\/li>
        11. Miron, J, Picard, C, Lafaille-Magnan, M\u00c9, Savard, M, Labont\u00e9, A, Breitner, J\u00a0et al.<\/i>. Association of TLR4 with Alzheimer’s disease risk and presymptomatic biomarkers of inflammation. Alzheimers Dement. 2019;15 (7):951-960. doi:\u00a010.1016\/j.jalz.2019.03.012<\/a>. PubMed\u00a0PMID:31175027<\/a>\u00a0.<\/li>
        12. Pascoal, TA, Mathotaarachchi, S, Kang, MS, Mohaddes, S, Shin, M, Park, AY\u00a0et al.<\/i>. A\u03b2-induced vulnerability propagates via the brain’s default mode network. Nat Commun. 2019;10 (1):2353. doi:\u00a010.1038\/s41467-019-10217-w<\/a>. PubMed\u00a0PMID:31164641<\/a>\u00a0PubMed Central\u00a0PMC6547716<\/a>.<\/li>
        13. Liebsch, F, Kulic, L, Teunissen, C, Shobo, A, Ulku, I, Engelschalt, V\u00a0et al.<\/i>. A\u03b234 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression. Nat Commun. 2019;10 (1):2240. doi:\u00a010.1038\/s41467-019-10152-w<\/a>. PubMed\u00a0PMID:31110178<\/a>\u00a0PubMed Central\u00a0PMC6527709<\/a>.<\/li>
        14. Bailey, JJ, Kaiser, L, Lindner, S, W\u00fcst, M, Thiel, A, Soucy, JP\u00a0et al.<\/i>. First-in-Human Brain Imaging of [18<\/sup>F]TRACK, a PET tracer for Tropomyosin Receptor Kinases. ACS Chem Neurosci. 2019;10 (6):2697-2702. doi:\u00a010.1021\/acschemneuro.9b00144<\/a>. PubMed\u00a0PMID:31017386<\/a>\u00a0.<\/li>
        15. Lle\u00f3, A, Alcolea, D, Mart\u00ednez-Lage, P, Scheltens, P, Parnetti, L, Poirier, J\u00a0et al.<\/i>. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer’s disease continuum in the BIOMARKAPD study. Alzheimers Dement. 2019;15 (6):742-753. doi:\u00a010.1016\/j.jalz.2019.01.015<\/a>. PubMed\u00a0PMID:30967340<\/a>\u00a0.<\/li>
        16. Meyer, PF, Tremblay-Mercier, J, Leoutsakos, J, Madjar, C, Lafaille-Maignan, M\u00c9, Savard, M\u00a0et al.<\/i>. INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology. 2019;92 (18):e2070-e2080. doi:\u00a010.1212\/WNL.0000000000007232<\/a>. PubMed\u00a0PMID:30952794<\/a>\u00a0PubMed Central\u00a0PMC6512884<\/a>.<\/li>
        17. Miranda, A, Kang, MS, Blinder, S, Bouhachi, R, Soucy, JP, Aliaga-Aliaga, A\u00a0et al.<\/i>. PET imaging of freely moving interacting rats. Neuroimage. 2019;191 :560-567. doi:\u00a010.1016\/j.neuroimage.2019.02.064<\/a>. PubMed\u00a0PMID:30831313<\/a>\u00a0.<\/li>
        18. Liu, J, Wang, Q, Jing, D, Gao, R, Zhang, J, Cui, C\u00a0et al.<\/i>. Diagnostic Approach of Early-Onset Dementia with Negative Family History: Implications from Two Cases of Early-Onset Alzheimer’s Disease with De Novo PSEN1 Mutation. J Alzheimers Dis. 2019;68 (2):551-558. doi:\u00a010.3233\/JAD-181108<\/a>. PubMed\u00a0PMID:30814350<\/a>\u00a0.<\/li>
        19. Sheynin, Y, Chamoun, M, Baldwin, AS,\u00a0Rosa-Neto, P<\/strong>, Hess, RF, Vaucher, E\u00a0et al.<\/i>. Cholinergic Potentiation Alters Perceptual Eye Dominance Plasticity Induced by a Few Hours of Monocular Patching in Adults. Front Neurosci. 2019;13 :22. doi:\u00a010.3389\/fnins.2019.00022<\/a>. PubMed\u00a0PMID:30766471<\/a>\u00a0PubMed Central\u00a0PMC6365463<\/a>.<\/li>
        20. Uribe, CF, Mathotaarachchi, S, Gaudet, V, Smith, KC,\u00a0Rosa-Neto, P<\/strong>, B\u00e9nard, F\u00a0et al.<\/i>. Machine Learning in Nuclear Medicine: Part 1-Introduction. J Nucl Med. 2019;60 (4):451-458. doi:\u00a010.2967\/jnumed.118.223495<\/a>. PubMed\u00a0PMID:30733322<\/a>\u00a0.<\/li>
        21. Jiang, L, Oualkacha, K, Didelez, V, Ciampi, A,\u00a0Rosa-Neto, P<\/strong>, Benedet, AL\u00a0et al.<\/i>. Constrained instruments and their application to Mendelian randomization with pleiotropy. Genet Epidemiol. 2019;43 (4):373-401. doi:\u00a010.1002\/gepi.22184<\/a>. PubMed\u00a0PMID:30635941<\/a>\u00a0PubMed Central\u00a0PMC6537099<\/a>.<\/li>
        22. Carter, SF, Herholz, K,\u00a0Rosa-Neto, P<\/strong>, Pellerin, L, Nordberg, A, Zimmer, ER\u00a0et al.<\/i>. Astrocyte Biomarkers in Alzheimer’s Disease. Trends Mol Med. 2019;25 (2):77-95. doi:\u00a010.1016\/j.molmed.2018.11.006<\/a>. PubMed\u00a0PMID:30611668<\/a>\u00a0.<\/li>
        23. Schirrmacher, R, Bailey, JJ, Mossine, AV, Scott, PJH, Kaiser, L, Bartenstein, P\u00a0et al.<\/i>. Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging. Pharmaceuticals (Basel). 2019;12 (1):. doi:\u00a010.3390\/ph12010007<\/a>. PubMed\u00a0PMID:30609832<\/a>\u00a0PubMed Central\u00a0PMC6469173<\/a>.<\/li>
        24. Lam, J, DuBois, JM, Rowley, J, Gonz\u00e1lez-Ot\u00e1rula, KA, Soucy, JP, Massarweh, G\u00a0et al.<\/i>. In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy. Ann Neurol. 2019;85 (2):218-228. doi:\u00a010.1002\/ana.25404<\/a>. PubMed\u00a0PMID:30597619<\/a>\u00a0.<\/li>
        25. Hopewell, R, Ross, K, Kostikov, A, Pascoal, TA, Alberti, T, Lacatus-Samoila, M\u00a0et al.<\/i>. A simplified radiosynthesis of [18<\/sup>\u00a0F]MK-6240 for tau PET imaging. J Labelled Comp Radiopharm. 2019;62 (2):109-114. doi:\u00a010.1002\/jlcr.3695<\/a>. PubMed\u00a0PMID:30426529<\/a>\u00a0.<\/li>
        26. Schilling, LP, Pascoal, TA, Zimmer, ER, Mathotaarachchi, S, Shin, M, de Mello Rieder, CR\u00a0et al.<\/i>. Regional Amyloid-\u03b2 Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia. Mol Neurobiol. 2019;56 (7):4916-4924. doi:\u00a010.1007\/s12035-018-1405-1<\/a>. PubMed\u00a0PMID:30414086<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t

          2018<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t\t\t\t\t
          1. Zhang, H, Ng, KP, Therriault, J, Kang, MS, Pascoal, TA,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease. Transl Neurodegener. 2018;7 :23. doi:\u00a010.1186\/s40035-018-0127-7<\/a>. PubMed\u00a0PMID:30311914<\/a>\u00a0PubMed Central\u00a0PMC6161434<\/a>.<\/li>
          2. Ng, KP, Chiew, HJ, Lim, L,\u00a0Rosa-Neto, P<\/strong>, Kandiah, N, Gauthier, S\u00a0et al.<\/i>. The influence of language and culture on cognitive assessment tools in the diagnosis of early cognitive impairment and dementia. Expert Rev Neurother. 2018;18 (11):859-869. doi:\u00a010.1080\/14737175.2018.1532792<\/a>. PubMed\u00a0PMID:30286681<\/a>\u00a0.<\/li>
          3. Zhang, H, Therriault, J, Kang, MS, Ng, KP, Pascoal, TA,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease. Alzheimers Res Ther. 2018;10 (1):80. doi:\u00a010.1186\/s13195-018-0407-6<\/a>. PubMed\u00a0PMID:30115118<\/a>\u00a0PubMed Central\u00a0PMC6097333<\/a>.<\/li>
          4. Gauthier, S, Herrmann, N,\u00a0Rosa-Neto, P<\/strong>. Optimal use of cholinergic drugs in Alzheimer’s disease. Brain. 2018;141 (9):e68. doi:\u00a010.1093\/brain\/awy204<\/a>. PubMed\u00a0PMID:30084978<\/a>\u00a0.<\/li>
          5. Pascoal, TA, Shin, M, Kang, MS, Chamoun, M, Chartrand, D, Mathotaarachchi, S\u00a0et al.<\/i>. In vivo quantification of neurofibrillary tangles with [18<\/sup>F]MK-6240. Alzheimers Res Ther. 2018;10 (1):74. doi:\u00a010.1186\/s13195-018-0402-y<\/a>. PubMed\u00a0PMID:30064520<\/a>\u00a0PubMed Central\u00a0PMC6069775<\/a>.<\/li>
          6. Guadagno, A, Kang, MS, Devenyi, GA, Mathieu, AP,\u00a0Rosa-Neto, P<\/strong>, Chakravarty, M\u00a0et al.<\/i>. Reduced resting-state functional connectivity of the basolateral amygdala to the medial prefrontal cortex in preweaning rats exposed to chronic early-life stress. Brain Struct Funct. 2018;223 (8):3711-3729. doi:\u00a010.1007\/s00429-018-1720-3<\/a>. PubMed\u00a0PMID:30032360<\/a>\u00a0.<\/li>
          7. Zukotynski, K, Kuo, PH, Mikulis, D,\u00a0Rosa-Neto, P<\/strong>, Strafella, AP, Subramaniam, RM\u00a0et al.<\/i>. PET\/CT of Dementia. AJR Am J Roentgenol. 2018;211 (2):246-259. doi:\u00a010.2214\/AJR.18.19822<\/a>. PubMed\u00a0PMID:29949415<\/a>\u00a0.<\/li>
          8. Smart, K, Cox, SML, Nagano-Saito, A,\u00a0Rosa-Neto, P<\/strong>, Leyton, M, Benkelfat, C\u00a0et al.<\/i>. Test-retest variability of [11<\/sup>\u00a0C]ABP688 estimates of metabotropic glutamate receptor subtype 5 availability in humans. Synapse. 2018;72 (9):e22041. doi:\u00a010.1002\/syn.22041<\/a>. PubMed\u00a0PMID:29935121<\/a>\u00a0.<\/li>
          9. Gauthier, S, Zhang, H, Ng, KP, Pascoal, TA,\u00a0Rosa-Neto, P<\/strong>. Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?. Transl Neurodegener. 2018;7 :12. doi:\u00a010.1186\/s40035-018-0117-9<\/a>. PubMed\u00a0PMID:29876101<\/a>\u00a0PubMed Central\u00a0PMC5977549<\/a>.<\/li>
          10. Meyer, PF, Savard, M, Poirier, J, Labont\u00e9, A,\u00a0Rosa-Neto, P<\/strong>, Weitz, TM\u00a0et al.<\/i>. Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of\u00a0Alzheimer’s Disease Pathogenesis. J Alzheimers Dis. 2018;63 (2):577-590. doi:\u00a010.3233\/JAD-170887<\/a>. PubMed\u00a0PMID:29660934<\/a>\u00a0PubMed Central\u00a0PMC5929310<\/a>.<\/li>
          11. Gauthier, S, Ng, KP, Pascoal, TA, Zhang, H,\u00a0Rosa-Neto, P<\/strong>. Targeting Alzheimer’s Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment. J Alzheimers Dis. 2018;64 (s1):S23-S31. doi:\u00a010.3233\/JAD-179924<\/a>. PubMed\u00a0PMID:29504543<\/a>\u00a0PubMed Central\u00a0PMC6004905<\/a>.<\/li>
          12. Villeneuve, S, Vogel, JW, Gonneaud, J, Pichet Binette, A,\u00a0Rosa-Neto, P<\/strong>, Gauthier, S\u00a0et al.<\/i>. Proximity to Parental Symptom Onset and Amyloid-\u03b2 Burden in Sporadic Alzheimer Disease. JAMA Neurol. 2018;75 (5):608-619. doi:\u00a010.1001\/jamaneurol.2017.5135<\/a>. PubMed\u00a0PMID:29482212<\/a>\u00a0PubMed Central\u00a0PMC5885216<\/a>.<\/li>
          13. Benedet, AL, Yu, L, Labbe, A, Mathotaarachchi, S, Pascoal, TA, Shin, M\u00a0et al.<\/i>.\u00a0CYP2C19<\/i>\u00a0variant mitigates Alzheimer disease pathophysiology\u00a0in vivo<\/i>\u00a0and postmortem. Neurol Genet. 2018;4 (1):e216. doi:\u00a010.1212\/NXG.0000000000000216<\/a>. PubMed\u00a0PMID:29473050<\/a>\u00a0PubMed Central\u00a0PMC5820598<\/a>.<\/li>
          14. Therriault, J, Ng, KP, Pascoal, TA, Mathotaarachchi, S, Kang, MS, Struyfs, H\u00a0et al.<\/i>. Anosognosia predicts default mode network hypometabolism and clinical progression to dementia. Neurology. 2018;90 (11):e932-e939. doi:\u00a010.1212\/WNL.0000000000005120<\/a>. PubMed\u00a0PMID:29444971<\/a>\u00a0PubMed Central\u00a0PMC5858945<\/a>.<\/li>
          15. Pascoal, TA, Mathotaarachchi, S, Shin, M, Park, AY, Mohades, S, Benedet, AL\u00a0et al.<\/i>. Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2018;45 (6):1021-1030. doi:\u00a010.1007\/s00259-018-3933-3<\/a>. PubMed\u00a0PMID:29396637<\/a>\u00a0PubMed Central\u00a0PMC5915512<\/a>.<\/li>
          16. Henriques, AD, Benedet, AL, Camargos, EF,\u00a0Rosa-Neto, P<\/strong>, N\u00f3brega, OT. Fluid and imaging biomarkers for Alzheimer’s disease: Where we stand and where to head to. Exp Gerontol. 2018;107 :169-177. doi:\u00a010.1016\/j.exger.2018.01.002<\/a>. PubMed\u00a0PMID:29307736<\/a>\u00a0PubMed Central\u00a0PMC5951730<\/a>.<\/li>
          17. Bernard-Gauthier, V, Mossine, AV, Mahringer, A, Aliaga, A, Bailey, JJ, Shao, X\u00a0et al.<\/i>. Identification of [18<\/sup>F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging. J Med Chem. 2018;61 (4):1737-1743. doi:\u00a010.1021\/acs.jmedchem.7b01607<\/a>. PubMed\u00a0PMID:29257860<\/a>\u00a0.<\/li>
          18. Tardif, CL, Devenyi, GA, Amaral, RSC, Pelleieux, S, Poirier, J,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer’s disease. Hum Brain Mapp. 2018;39 (2):971-984. doi:\u00a010.1002\/hbm.23897<\/a>. PubMed\u00a0PMID:29164798<\/a>\u00a0PubMed Central\u00a0PMC6866392<\/a>.<\/li>
          19. Li, X, Ba, M, Ng, KP, Mathotaarachchi, S, Pascoal, TA,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Characterizing biomarker features of cognitively normal individuals with ventriculomegaly. Alzheimers Dement (Amst). 2018;10 :12-21. doi:\u00a010.1016\/j.dadm.2017.08.001<\/a>. PubMed\u00a0PMID:29159265<\/a>\u00a0PubMed Central\u00a0PMC5678356<\/a>.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t

            2017<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t
            1. Parent, MJ, Zimmer, ER, Shin, M, Kang, MS, Fonov, VS, Mathieu, A\u00a0et al.<\/i>. Multimodal Imaging in Rat Model Recapitulates Alzheimer’s Disease Biomarkers Abnormalities. J Neurosci. 2017;37 (50):12263-12271. doi:\u00a010.1523\/JNEUROSCI.1346-17.2017<\/a>. PubMed\u00a0PMID:29097597<\/a>\u00a0PubMed Central\u00a0PMC5729194<\/a>.<\/li>
            2. Gauthier, S, Ng, KP, Pascoal, TA, Mathotaarachchi, S, Chung, CO, Benedetti, AL\u00a0et al.<\/i>. Author response: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease. Neurology. 2017;89 (18):1931. doi:\u00a010.1212\/WNL.0000000000004593<\/a>. PubMed\u00a0PMID:29084927<\/a>\u00a0.<\/li>
            3. Ba, M, Li, X, Ng, KP, Pascoal, TA, Mathotaarachchi, S,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer’s disease from the Alzheimer’s Disease Neuroimaging Initiative database. Alzheimers Dement (N Y). 2017;3 (1):107-113. doi:\u00a010.1016\/j.trci.2016.12.005<\/a>. PubMed\u00a0PMID:29067322<\/a>\u00a0PubMed Central\u00a0PMC5651370<\/a>.<\/li>
            4. Tuwaig, M, Savard, M, Jutras, B, Poirier, J, Collins, DL,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer’s Disease. J Alzheimers Dis. 2017;60 (4):1589-1600. doi:\u00a010.3233\/JAD-170545<\/a>. PubMed\u00a0PMID:28984583<\/a>\u00a0PubMed Central\u00a0PMC5757649<\/a>.<\/li>
            5. Aghourian, M, Legault-Denis, C, Soucy, JP,\u00a0Rosa-Neto, P<\/strong>, Gauthier, S, Kostikov, A\u00a0et al.<\/i>. Quantification of brain cholinergic denervation in Alzheimer’s disease using PET imaging with [18<\/sup>F]-FEOBV. Mol Psychiatry. 2017;22 (11):1531-1538. doi:\u00a010.1038\/mp.2017.183<\/a>. PubMed\u00a0PMID:28894304<\/a>\u00a0.<\/li>
            6. Mathotaarachchi, S, Pascoal, TA, Shin, M, Benedet, AL, Kang, MS, Beaudry, T\u00a0et al.<\/i>. Identifying incipient dementia individuals using machine learning and amyloid imaging. Neurobiol Aging. 2017;59 :80-90. doi:\u00a010.1016\/j.neurobiolaging.2017.06.027<\/a>. PubMed\u00a0PMID:28756942<\/a>\u00a0.<\/li>
            7. Bernard-Gauthier, V, Bailey, JJ, Mossine, AV, Lindner, S, Vomacka, L, Aliaga, A\u00a0et al.<\/i>. A Kinome-Wide Selective Radiolabeled TrkB\/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human. J Med Chem. 2017;60 (16):6897-6910. doi:\u00a010.1021\/acs.jmedchem.7b00396<\/a>. PubMed\u00a0PMID:28696690<\/a>\u00a0.<\/li>
            8. Lafaille-Magnan, ME, Poirier, J, Etienne, P, Tremblay-Mercier, J, Frenette, J,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Odor identification as a biomarker of preclinical AD in older adults at risk. Neurology. 2017;89 (4):327-335. doi:\u00a010.1212\/WNL.0000000000004159<\/a>. PubMed\u00a0PMID:28659431<\/a>\u00a0PubMed Central\u00a0PMC5574678<\/a>.<\/li>
            9. Engelborghs, S, Niemantsverdriet, E, Struyfs, H, Blennow, K, Brouns, R, Comabella, M\u00a0et al.<\/i>. Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst). 2017;8 :111-126. doi:\u00a010.1016\/j.dadm.2017.04.007<\/a>. PubMed\u00a0PMID:28603768<\/a>\u00a0PubMed Central\u00a0PMC5454085<\/a>.<\/li>
            10. Dadar, M, Pascoal, TA, Manitsirikul, S, Misquitta, K, Fonov, VS, Tartaglia, MC\u00a0et al.<\/i>. Validation of a Regression Technique for Segmentation of White Matter Hyperintensities in Alzheimer’s Disease. IEEE Trans Med Imaging. 2017;36 (8):1758-1768. doi:\u00a010.1109\/TMI.2017.2693978<\/a>. PubMed\u00a0PMID:28422655<\/a>\u00a0.<\/li>
            11. Ng, KP, Pascoal, TA, Mathotaarachchi, S, Chung, CO, Benedet, AL, Shin, M\u00a0et al.<\/i>. Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease. Neurology. 2017;88 (19):1814-1821. doi:\u00a010.1212\/WNL.0000000000003916<\/a>. PubMed\u00a0PMID:28404803<\/a>\u00a0PubMed Central\u00a0PMC5419982<\/a>.<\/li>
            12. Chamoun, M, Hupp\u00e9-Gourgues, F, Legault, I,\u00a0Rosa-Neto, P<\/strong>, Dumbrava, D, Faubert, J\u00a0et al.<\/i>. Cholinergic Potentiation Improves Perceptual-Cognitive Training of Healthy Young Adults in Three Dimensional Multiple Object Tracking. Front Hum Neurosci. 2017;11 :128. doi:\u00a010.3389\/fnhum.2017.00128<\/a>. PubMed\u00a0PMID:28377707<\/a>\u00a0PubMed Central\u00a0PMC5359296<\/a>.<\/li>
            13. Ng, KP, Pascoal, TA, Mathotaarachchi, S, Therriault, J, Kang, MS, Shin, M\u00a0et al.<\/i>. Monoamine oxidase B inhibitor, selegiline, reduces\u00a018<\/sup>F-THK5351 uptake in the human brain. Alzheimers Res Ther. 2017;9 (1):25. doi:\u00a010.1186\/s13195-017-0253-y<\/a>. PubMed\u00a0PMID:28359327<\/a>\u00a0PubMed Central\u00a0PMC5374697<\/a>.<\/li>
            14. Zimmer, ER, Parent, MJ, Souza, DG, Leuzy, A, Lecrux, C, Kim, HI\u00a0et al.<\/i>. [18<\/sup>F]FDG PET signal is driven by astroglial glutamate transport. Nat Neurosci. 2017;20 (3):393-395. doi:\u00a010.1038\/nn.4492<\/a>. PubMed\u00a0PMID:28135241<\/a>\u00a0PubMed Central\u00a0PMC5378483<\/a>.<\/li>
            15. Pascoal, TA, Mathotaarachchi, S, Shin, M, Benedet, AL, Mohades, S, Wang, S\u00a0et al.<\/i>. Synergistic interaction between amyloid and tau predicts the progression\u00a0to dementia. Alzheimers Dement. 2017;13 (6):644-653. doi:\u00a010.1016\/j.jalz.2016.11.005<\/a>. PubMed\u00a0PMID:28024995<\/a>\u00a0.<\/li>
            16. Pascoal, TA, Mathotaarachchi, S, Mohades, S, Benedet, AL, Chung, CO, Shin, M\u00a0et al.<\/i>. Amyloid-\u03b2 and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease. Mol Psychiatry. 2017;22 (2):306-311. doi:\u00a010.1038\/mp.2016.37<\/a>. PubMed\u00a0PMID:27021814<\/a>\u00a0PubMed Central\u00a0PMC5262471<\/a>.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t

              2016<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t\t\t\t\t
              1. Tam, A, Dansereau, C, Badhwar, A, Orban, P, Belleville, S, Chertkow, H\u00a0et al.<\/i>. A dataset of multiresolution functional brain parcellations in an elderly population with no or mild cognitive impairment. Data Brief. 2016;9 :1122-1129. doi:\u00a010.1016\/j.dib.2016.11.036<\/a>. PubMed\u00a0PMID:27924300<\/a>\u00a0PubMed Central\u00a0PMC5128734<\/a>.<\/li>
              2. Ba, M, Kong, M, Li, X, Ng, KP,\u00a0Rosa-Neto, P<\/strong>, Gauthier, S\u00a0et al.<\/i>. Is ApoE \u025b 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?. Transl Neurodegener. 2016;5 :20. doi:\u00a010.1186\/s40035-016-0067-z<\/a>. PubMed\u00a0PMID:27891223<\/a>\u00a0PubMed Central\u00a0PMC5112745<\/a>.<\/li>
              3. Mechling, AE, Arefin, T, Lee, HL, Bienert, T, Reisert, M, Ben Hamida, S\u00a0et al.<\/i>. Deletion of the mu opioid receptor gene in mice reshapes the reward-aversion connectome. Proc Natl Acad Sci U S A. 2016;113 (41):11603-11608. doi:\u00a010.1073\/pnas.1601640113<\/a>. PubMed\u00a0PMID:27671662<\/a>\u00a0PubMed Central\u00a0PMC5068324<\/a>.<\/li>
              4. DuBois, JM, Rousset, OG, Guiot, MC, Hall, JA, Reader, AJ, Soucy, JP\u00a0et al.<\/i>. Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [11C]ABP688 Positron-Emission Tomography (PET) Imaging. Cereb Cortex. 2016;26 (11):4170-4179. doi:\u00a010.1093\/cercor\/bhw249<\/a>. PubMed\u00a0PMID:27578494<\/a>\u00a0PubMed Central\u00a0PMC5066831<\/a>.<\/li>
              5. Gibon, J, Kang, MS, Aliaga, A, Sharif, B,\u00a0Rosa-Neto, P<\/strong>, S\u00e9gu\u00e9la, P\u00a0et al.<\/i>. Towards the PET radiotracer for p75 neurotrophin receptor: [(11)C]LM11A-24 shows biological activity\u00a0in vitro<\/i>, but unfavorable\u00a0ex vivo<\/i>\u00a0and\u00a0in vivo<\/i>\u00a0profile. Bioorg Med Chem. 2016;24 (19):4759-4765. doi:\u00a010.1016\/j.bmc.2016.08.020<\/a>. PubMed\u00a0PMID:27567078<\/a>\u00a0.<\/li>
              6. Mathotaarachchi, S, Wang, S, Shin, M, Pascoal, TA, Benedet, AL, Kang, MS\u00a0et al.<\/i>. VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis. Front Neuroinform. 2016;10 :20. doi:\u00a010.3389\/fninf.2016.00020<\/a>. PubMed\u00a0PMID:27378902<\/a>\u00a0PubMed Central\u00a0PMC4908129<\/a>.<\/li>
              7. Cho, J, Kwon, DH, Kim, RG, Song, H,\u00a0Rosa-Neto, P<\/strong>, Lee, MC\u00a0et al.<\/i>. Remodeling of Neuronal Circuits After Reach Training in Chronic Capsular Stroke. Neurorehabil Neural Repair. 2016;30 (10):941-950. doi:\u00a010.1177\/1545968316650282<\/a>. PubMed\u00a0PMID:27198184<\/a>\u00a0.<\/li>
              8. Gauthier, S,\u00a0Rosa-Neto, P<\/strong>, Kass, JS. Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients. Continuum (Minneap Minn). 2016;22 (2 Dementia):615-8. doi:\u00a010.1212\/CON.0000000000000306<\/a>. PubMed\u00a0PMID:27042911<\/a>\u00a0PubMed Central\u00a0PMC5390936<\/a>.<\/li>
              9. Schilling, LP, Zimmer, ER, Shin, M, Leuzy, A, Pascoal, TA, Benedet, AL\u00a0et al.<\/i>. Imaging Alzheimer’s disease pathophysiology with PET. Dement Neuropsychol. ;10 (2):79-90. doi:\u00a010.1590\/S1980-5764-2016DN1002003<\/a>. PubMed\u00a0PMID:29213438<\/a>\u00a0PubMed Central\u00a0PMC5642398<\/a>.<\/li>
              10. Pascoal, TA, Mathotaarachchi, S, Mohades, S, Benedet, AL, Chung, CO, Shin, M\u00a0et al.<\/i>. Amyloid-\u03b2 and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease. Mol Psychiatry. 2017;22 (2):306-311. doi:\u00a010.1038\/mp.2016.37<\/a>. PubMed\u00a0PMID:27021814<\/a>\u00a0PubMed Central\u00a0PMC5262471<\/a>.<\/li>
              11. Laforce, R,\u00a0Rosa-Neto, P<\/strong>, Soucy, JP, Rabinovici, GD, Dubois, B, Gauthier, S\u00a0et al.<\/i>. Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada. Can J Neurol Sci. 2016;43 (4):503-12. doi:\u00a010.1017\/cjn.2015.401<\/a>. PubMed\u00a0PMID:26916179<\/a>\u00a0.<\/li>
              12. Tomaszewski, S, Gauthier, S, Wimo, A,\u00a0Rosa-Neto, P<\/strong>. Combination Therapy of Anti-Tau and Anti-Amyloid Drugs for Disease Modification in Early-stage Alzheimer’s Disease: Socio-economic Considerations Modeled on Treatments for Tuberculosis, HIV\/AIDS and Breast Cancer. J Prev Alzheimers Dis. 2016;3 (3):164-172. doi:\u00a010.14283\/jpad.2015.85<\/a>. PubMed\u00a0PMID:29205255<\/a>\u00a0.<\/li>
              13. Kim, RG, Cho, J, Ree, J, Kim, HS,\u00a0Rosa-Neto, P<\/strong>, Kim, JM\u00a0et al.<\/i>. Sensory-parietal cortical stimulation improves motor recovery in severe capsular infarct. J Cereb Blood Flow Metab. 2016;36 (12):2211-2222. doi:\u00a010.1177\/0271678X15606136<\/a>. PubMed\u00a0PMID:26661148<\/a>\u00a0PubMed Central\u00a0PMC5363658<\/a>.<\/li>
              14. DuBois, JM, Rousset, OG, Rowley, J, Porras-Betancourt, M, Reader, AJ, Labbe, A\u00a0et al.<\/i>. Characterization of age\/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET. Eur J Nucl Med Mol Imaging. 2016;43 (1):152-162. doi:\u00a010.1007\/s00259-015-3167-6<\/a>. PubMed\u00a0PMID:26290423<\/a>\u00a0.<\/li>
              15. Leuzy, A, Zimmer, ER, Dubois, J, Pruessner, J, Cooperman, C, Soucy, JP\u00a0et al.<\/i>. In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD. Brain Struct Funct. 2016;221 (3):1387-402. doi:\u00a010.1007\/s00429-014-0978-3<\/a>. PubMed\u00a0PMID:25596865<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                \n\t\t\t\t
                \n\t\t\t\t\t

                2015<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                \n\t\t\t\t
                \n\t\t\t\t\t\t\t\t\t
                1. Tam, A, Dansereau, C, Badhwar, A, Orban, P, Belleville, S, Chertkow, H\u00a0et al.<\/i>. Common Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies. Front Aging Neurosci. 2015;7 :242. doi:\u00a010.3389\/fnagi.2015.00242<\/a>. PubMed\u00a0PMID:26733866<\/a>\u00a0PubMed Central\u00a0PMC4689788<\/a>.<\/li>
                2. Benedet, AL, Labbe, A, Lemay, P, Zimmer, ER, Pascoal, TA, Leuzy, A\u00a0et al.<\/i>. Epistasis analysis links immune cascades and cerebral amyloidosis. J Neuroinflammation. 2015;12 :227. doi:\u00a010.1186\/s12974-015-0436-z<\/a>. PubMed\u00a0PMID:26626881<\/a>\u00a0PubMed Central\u00a0PMC4666175<\/a>.<\/li>
                3. Orban, P, Madjar, C, Savard, M, Dansereau, C, Tam, A, Das, S\u00a0et al.<\/i>. Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer’s disease. Sci Data. 2015;2 :150043. doi:\u00a010.1038\/sdata.2015.43<\/a>. PubMed\u00a0PMID:26504522<\/a>\u00a0PubMed Central\u00a0PMC4603392<\/a>.<\/li>
                4. Zimmer, ER, Parent, MJ, Leuzy, A, Aliaga, A, Aliaga, A, Moquin, L\u00a0et al.<\/i>. Imaging\u00a0in vivo<\/i>\u00a0glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone. J Cereb Blood Flow Metab. 2015;35 (7):1169-74. doi:\u00a010.1038\/jcbfm.2015.35<\/a>. PubMed\u00a0PMID:25806702<\/a>\u00a0PubMed Central\u00a0PMC4640271<\/a>.<\/li>
                5. Bernard-Gauthier, V, Aliaga, A, Aliaga, A, Boudjemeline, M, Hopewell, R, Kostikov, A\u00a0et al.<\/i>. Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk) inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents. ACS Chem Neurosci. 2015;6 (2):260-76. doi:\u00a010.1021\/cn500193f<\/a>. PubMed\u00a0PMID:25350780<\/a>\u00a0.<\/li>
                6. Cyr, M, Parent, MJ, Mechawar, N,\u00a0Rosa-Neto, P<\/strong>, Soucy, JP, Clark, SD\u00a0et al.<\/i>. Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and\u00a0in vivo<\/i>\u00a0PET imaging with [\u00b9\u2078F]fluoroethoxybenzovesamicol. Behav Brain Res. 2015;278 :107-14. doi:\u00a010.1016\/j.bbr.2014.09.021<\/a>. PubMed\u00a0PMID:25257103<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                  \n\t\t\t\t
                  \n\t\t\t\t\t

                  2014<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                  \n\t\t\t\t
                  \n\t\t\t\t\t\t\t\t\t
                  1. Zimmer, ER, Leuzy, A, Gauthier, S,\u00a0Rosa-Neto, P<\/strong>. Developments in Tau PET Imaging. Can J Neurol Sci. 2014;41 (5):547-53. doi:\u00a010.1017\/cjn.2014.15<\/a>. PubMed\u00a0PMID:25424608<\/a>\u00a0.<\/li>
                  2. Zimmer, ER, Parent, MJ, Cuello, AC, Gauthier, S,\u00a0Rosa-Neto, P<\/strong>. MicroPET imaging and transgenic models: a blueprint for Alzheimer’s disease clinical research. Trends Neurosci. 2014;37 (11):629-41. doi:\u00a010.1016\/j.tins.2014.07.002<\/a>. PubMed\u00a0PMID:25151336<\/a>\u00a0.<\/li>
                  3. Zimmer, ER, Leuzy, A, Benedet, AL, Breitner, J, Gauthier, S,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging. J Neuroinflammation. 2014;11 :120. doi:\u00a010.1186\/1742-2094-11-120<\/a>. PubMed\u00a0PMID:25005532<\/a>\u00a0PubMed Central\u00a0PMC4099095<\/a>.<\/li>
                  4. Leuzy, A, Zimmer, ER, Heurling, K,\u00a0Rosa-Neto, P<\/strong>, Gauthier, S. Use of amyloid PET across the spectrum of Alzheimer’s disease: clinical utility and associated ethical issues. Amyloid. 2014;21 (3):143-8. doi:\u00a010.3109\/13506129.2014.926267<\/a>. PubMed\u00a0PMID:24919109<\/a>\u00a0.<\/li>
                  5. Ongali, B, Nicolakakis, N, Tong, XK, Aboulkassim, T, Papadopoulos, P,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer’s disease model. Neurobiol Dis. 2014;68 :126-36. doi:\u00a010.1016\/j.nbd.2014.04.018<\/a>. PubMed\u00a0PMID:24807206<\/a>\u00a0.<\/li>
                  6. Milella, MS, Marengo, L, Larcher, K, Fotros, A, Dagher, A,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study. Neuroimage. 2014;98 :195-202. doi:\u00a010.1016\/j.neuroimage.2014.04.061<\/a>. PubMed\u00a0PMID:24795154<\/a>\u00a0.<\/li>
                  7. Zimmer, ER, Leuzy, A, Bhat, V, Gauthier, S,\u00a0Rosa-Neto, P<\/strong>. In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals. Transl Neurodegener. 2014;3 (1):6. doi:\u00a010.1186\/2047-9158-3-6<\/a>. PubMed\u00a0PMID:24628994<\/a>\u00a0PubMed Central\u00a0PMC3995516<\/a>.<\/li>
                  8. Wu, L, Soder, RB, Schoemaker, D, Carbonnell, F, Sziklas, V, Rowley, J\u00a0et al.<\/i>. Resting state executive control network adaptations in amnestic mild cognitive impairment. J Alzheimers Dis. 2014;40 (4):993-1004. doi:\u00a010.3233\/JAD-131574<\/a>. PubMed\u00a0PMID:24583406<\/a>\u00a0.<\/li>
                  9. Leuzy, A, Zimmer, ER, Bhat, V,\u00a0Rosa-Neto, P<\/strong>, Gauthier, S. Imaging biomarkers for amyloid: a new generation of probes and what lies ahead. Int Psychogeriatr. 2014;26 (5):703-7. doi:\u00a010.1017\/S1041610214000118<\/a>. PubMed\u00a0PMID:24524685<\/a>\u00a0.<\/li>
                  10. Cyr, M, Parent, MJ, Mechawar, N,\u00a0Rosa-Neto, P<\/strong>, Soucy, JP, Aliaga, A\u00a0et al.<\/i>. PET imaging with [\u00b9\u2078F]fluoroethoxybenzovesamicol ([\u00b9\u2078F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat. Nucl Med Biol. 2014;41 (1):96-101. doi:\u00a010.1016\/j.nucmedbio.2013.10.004<\/a>. PubMed\u00a0PMID:24267056<\/a>\u00a0.<\/li>
                  11. Gauthier, S, Leuzy, A,\u00a0Rosa-Neto, P<\/strong>. How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer’s disease?. Neurodegener Dis. 2014;13 (2-3):197-9. doi:\u00a010.1159\/000353748<\/a>. PubMed\u00a0PMID:23942173<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                    \n\t\t\t\t
                    \n\t\t\t\t\t

                    2013<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                    \n\t\t\t\t
                    \n\t\t\t\t\t\t\t\t\t
                    1. Rosa-Neto, P<\/strong>, Hsiung, GY, Masellis, M, CCDTD4 participants. Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians. Alzheimers Res Ther. 2013;5 (Suppl 1):S8. doi:\u00a010.1186\/alzrt223<\/a>. PubMed\u00a0PMID:24565514<\/a>\u00a0PubMed Central\u00a0PMC3980280<\/a>.<\/li>
                    2. Burhan, AM, Bartha, R, Bocti, C, Borrie, M, Laforce, R,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimers Res Ther. 2013;5 (Suppl 1):S4. doi:\u00a010.1186\/alzrt200<\/a>. PubMed\u00a0PMID:24565285<\/a>\u00a0PubMed Central\u00a0PMC3981649<\/a>.<\/li>
                    3. Soucy, JP, Bartha, R, Bocti, C, Borrie, M, Burhan, AM, Laforce, R\u00a0et al.<\/i>. Clinical applications of neuroimaging in patients with Alzheimer’s disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimers Res Ther. 2013;5 (Suppl 1):S3. doi:\u00a010.1186\/alzrt199<\/a>. PubMed\u00a0PMID:24565260<\/a>\u00a0PubMed Central\u00a0PMC3980588<\/a>.<\/li>
                    4. Parent, MJ, Bedard, MA, Aliaga, A, Minuzzi, L, Mechawar, N, Soucy, JP\u00a0et al.<\/i>. Cholinergic Depletion in Alzheimer’s Disease Shown by [ (18) F]FEOBV Autoradiography. Int J Mol Imaging. 2013;2013 :205045. doi:\u00a010.1155\/2013\/205045<\/a>. PubMed\u00a0PMID:24324884<\/a>\u00a0PubMed Central\u00a0PMC3844185<\/a>.<\/li>
                    5. Bernard-Gauthier, V, Boudjemeline, M,\u00a0Rosa-Neto, P<\/strong>, Thiel, A, Schirrmacher, R. Towards tropomyosin-related kinase B (TrkB) receptor ligands for brain imaging with PET: radiosynthesis and evaluation of 2-(4-[(18)F]fluorophenyl)-7,8-dihydroxy-4H-chromen-4-one and 2-(4-([N-methyl-(11)C]-dimethylamino)phenyl)-7,8-dihydroxy-4H-chromen-4-one. Bioorg Med Chem. 2013;21 (24):7816-29. doi:\u00a010.1016\/j.bmc.2013.10.012<\/a>. PubMed\u00a0PMID:24183588<\/a>\u00a0.<\/li>
                    6. Gauthier, S,\u00a0Rosa-Neto, P<\/strong>. Dementia: Disclosure of results to participants in dementia research. Nat Rev Neurol. 2013;9 (11):608-9. doi:\u00a010.1038\/nrneurol.2013.213<\/a>. PubMed\u00a0PMID:24145370<\/a>\u00a0.<\/li>
                    7. Parent, MJ, Cyr, M, Aliaga, A, Kostikov, A, Schirrmacher, E, Soucy, JP\u00a0et al.<\/i>. Concordance between\u00a0in vivo<\/i>\u00a0and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry. EJNMMI Res. 2013;3 (1):70. doi:\u00a010.1186\/2191-219X-3-70<\/a>. PubMed\u00a0PMID:24103360<\/a>\u00a0PubMed Central\u00a0PMC3852759<\/a>.<\/li>
                    8. Rowley, J, Fonov, V, Wu, O, Eskildsen, SF, Schoemaker, D, Wu, L\u00a0et al.<\/i>. White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer’s disease. PLoS One. 2013;8 (9):e74776. doi:\u00a010.1371\/journal.pone.0074776<\/a>. PubMed\u00a0PMID:24086371<\/a>\u00a0PubMed Central\u00a0PMC3785512<\/a>.<\/li>
                    9. Papadopoulos, P,\u00a0Rosa-Neto, P<\/strong>, Rochford, J, Hamel, E. Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer’s disease with combined amyloid-\u03b2 and cerebrovascular pathology. PLoS One. 2013;8 (7):e68612. doi:\u00a010.1371\/journal.pone.0068612<\/a>. PubMed\u00a0PMID:23874687<\/a>\u00a0PubMed Central\u00a0PMC3715495<\/a>.<\/li>
                    10. Kandratavicius, L,\u00a0Rosa-Neto, P<\/strong>, Monteiro, MR, Guiot, MC, Assirati, JA Jr, Carlotti, CG Jr\u00a0et al.<\/i>. Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis. Hippocampus. 2013;23 (12):1212-30. doi:\u00a010.1002\/hipo.22160<\/a>. PubMed\u00a0PMID:23804486<\/a>\u00a0PubMed Central\u00a0PMC4165311<\/a>.<\/li>
                    11. Gauthier, S, Leuzy, A, Racine, E,\u00a0Rosa-Neto, P<\/strong>. Diagnosis and management of Alzheimer’s disease: past, present and future ethical issues. Prog Neurobiol. 2013;110 :102-13. doi:\u00a010.1016\/j.pneurobio.2013.01.003<\/a>. PubMed\u00a0PMID:23578568<\/a>\u00a0.<\/li>
                    12. Zhao, L, Boucher, M,\u00a0Rosa-Neto, P<\/strong>, Evans, AC. Impact of scale space search on age- and gender-related changes in MRI-based cortical morphometry. Hum Brain Mapp. 2013;34 (9):2113-28. doi:\u00a010.1002\/hbm.22050<\/a>. PubMed\u00a0PMID:22422546<\/a>\u00a0PubMed Central\u00a0PMC6870203<\/a>.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                      \n\t\t\t\t
                      \n\t\t\t\t\t

                      2012<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                      \n\t\t\t\t
                      \n\t\t\t\t\t\t\t\t\t
                      1. Gauthier, S, Patterson, C, Chertkow, H, Gordon, M, Herrmann, N, Rockwood, K\u00a0et al.<\/i>. Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4). Can Geriatr J. 2012;15 (4):120-6. doi:\u00a010.5770\/cgj.15.49<\/a>. PubMed\u00a0PMID:23259025<\/a>\u00a0PubMed Central\u00a0PMC3516356<\/a>.<\/li>
                      2. Gauthier, S, Patterson, C, Chertkow, H, Gordon, M, Herrmann, N, Rockwood, K\u00a0et al.<\/i>. 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia. Can J Neurol Sci. 2012;39 (6 Suppl 5):S1-8. doi:\u00a010.1017\/s0317167100015183<\/a>. PubMed\u00a0PMID:23073396<\/a>\u00a0.<\/li>
                      3. Gauthier, S, Wu, L,\u00a0Rosa-Neto, P<\/strong>, Jia, J. Prevention strategies for Alzheimer’s disease. Transl Neurodegener. 2012;1 (1):13. doi:\u00a010.1186\/2047-9158-1-13<\/a>. PubMed\u00a0PMID:23210473<\/a>\u00a0PubMed Central\u00a0PMC3514088<\/a>.<\/li>
                      4. Wu, L, Rowley, J, Mohades, S, Leuzy, A, Dauar, MT, Shin, M\u00a0et al.<\/i>. Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment. PLoS One. 2012;7 (10):e47905. doi:\u00a010.1371\/journal.pone.0047905<\/a>. PubMed\u00a0PMID:23112868<\/a>\u00a0PubMed Central\u00a0PMC3480449<\/a>.<\/li>
                      5. Wu, L,\u00a0Rosa-Neto, P<\/strong>, Hsiung, GY, Sadovnick, AD, Masellis, M, Black, SE\u00a0et al.<\/i>. Early-onset familial Alzheimer’s disease (EOFAD). Can J Neurol Sci. 2012;39 (4):436-45. doi:\u00a010.1017\/s0317167100013949<\/a>. PubMed\u00a0PMID:22728850<\/a>\u00a0.<\/li>
                      6. Parent, M, Bedard, MA, Aliaga, A, Soucy, JP, Landry St-Pierre, E, Cyr, M\u00a0et al.<\/i>. PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol ([18F]FEOBV). Neuroimage. 2012;62 (1):555-61. doi:\u00a010.1016\/j.neuroimage.2012.04.032<\/a>. PubMed\u00a0PMID:22555071<\/a>\u00a0.<\/li>
                      7. Tong, XK, Lecrux, C,\u00a0Rosa-Neto, P<\/strong>, Hamel, E. Age-dependent rescue by simvastatin of Alzheimer’s disease cerebrovascular and memory deficits. J Neurosci. 2012;32 (14):4705-15. doi:\u00a010.1523\/JNEUROSCI.0169-12.2012<\/a>. PubMed\u00a0PMID:22492027<\/a>\u00a0PubMed Central\u00a0PMC6620905<\/a>.<\/li>
                      8. Kova\u010devi\u0107, T, Skelin, I, Minuzzi, L,\u00a0Rosa-Neto, P<\/strong>, Diksic, M. Reduced metabotropic glutamate receptor 5 in the Flinders Sensitive Line of rats, an animal model of depression: an autoradiographic study. Brain Res Bull. 2012;87 (4-5):406-12. doi:\u00a010.1016\/j.brainresbull.2012.01.010<\/a>. PubMed\u00a0PMID:22310150<\/a>\u00a0PubMed Central\u00a0PMC3641045<\/a>.<\/li>
                      9. Elmenhorst, D, Aliaga, A, Bauer, A,\u00a0Rosa-Neto, P<\/strong>. Test-retest stability of cerebral mGluR\u2085 quantification using [\u00b9\u00b9C]ABP688 and positron emission tomography in rats. Synapse. 2012;66 (6):552-60. doi:\u00a010.1002\/syn.21542<\/a>. PubMed\u00a0PMID:22290765<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                        \n\t\t\t\t
                        \n\t\t\t\t\t

                        2011<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                        \n\t\t\t\t
                        \n\t\t\t\t\t\t\t\t\t
                        1. Berney, A, Leyton, M, Gravel, P, Sibon, I, Sookman, D, Rosa Neto, P\u00a0et al.<\/i>. Brain regional \u03b1-[11C]methyl-L-tryptophan trapping in medication-free patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 2011;68 (7):732-41. doi:\u00a010.1001\/archgenpsychiatry.2011.16<\/a>. PubMed\u00a0PMID:21383250<\/a>\u00a0PubMed Central\u00a0PMC3677917<\/a>.<\/li>
                        2. Chen, ZJ, He, Y,\u00a0Rosa-Neto, P<\/strong>, Gong, G, Evans, AC. Age-related alterations in the modular organization of structural cortical network by using cortical thickness from MRI. Neuroimage. 2011;56 (1):235-45. doi:\u00a010.1016\/j.neuroimage.2011.01.010<\/a>. PubMed\u00a0PMID:21238595<\/a>\u00a0.<\/li>
                        3. Oishi, K, Huang, H, Yoshioka, T, Ying, SH, Zee, DS, Zilles, K\u00a0et al.<\/i>. Superficially located white matter structures commonly seen in the human and the macaque brain with diffusion tensor imaging. Brain Connect. 2011;1 (1):37-47. doi:\u00a010.1089\/brain.2011.0005<\/a>. PubMed\u00a0PMID:22432953<\/a>\u00a0PubMed Central\u00a0PMC3569096<\/a>.<\/li>
                        4. Nicolakakis, N, Aboulkassim, T, Aliaga, A, Tong, XK,\u00a0Rosa-Neto, P<\/strong>, Hamel, E\u00a0et al.<\/i>. Intact memory in TGF-\u03b21 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone. J Cereb Blood Flow Metab. 2011;31 (1):200-11. doi:\u00a010.1038\/jcbfm.2010.78<\/a>. PubMed\u00a0PMID:20571524<\/a>\u00a0PubMed Central\u00a0PMC3049484<\/a>.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                          \n\t\t\t\t
                          \n\t\t\t\t\t

                          2010<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                          \n\t\t\t\t
                          \n\t\t\t\t\t\t\t\t\t
                          1. Ongali, B, Nicolakakis, N, Lecrux, C, Aboulkassim, T,\u00a0Rosa-Neto, P<\/strong>, Papadopoulos, P\u00a0et al.<\/i>. Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer’s disease. Am J Pathol. 2010;177 (6):3071-80. doi:\u00a010.2353\/ajpath.2010.100339<\/a>. PubMed\u00a0PMID:21088218<\/a>\u00a0PubMed Central\u00a0PMC2993264<\/a>.<\/li>
                          2. Bertomeu, T, Zvereff, V, Ibrahim, A, Zehntner, SP, Aliaga, A,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. TLN-4601 peripheral benzodiazepine receptor (PBR\/TSPO) binding properties do not mediate apoptosis but confer tumor-specific accumulation. Biochem Pharmacol. 2010;80 (10):1572-9. doi:\u00a010.1016\/j.bcp.2010.07.018<\/a>. PubMed\u00a0PMID:20655882<\/a>\u00a0.<\/li>
                          3. Verhaeghe, J, Gravel, P, Mio, R, Fukasawa, R,\u00a0Rosa-Neto, P<\/strong>, Soucy, JP\u00a0et al.<\/i>. Motion compensation for fully 4D PET reconstruction using PET superset data. Phys Med Biol. 2010;55 (14):4063-82. doi:\u00a010.1088\/0031-9155\/55\/14\/008<\/a>. PubMed\u00a0PMID:20601774<\/a>\u00a0.<\/li>
                          4. Zhang, Y, Zhang, J, Oishi, K, Faria, AV, Jiang, H, Li, X\u00a0et al.<\/i>. Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy. Neuroimage. 2010;52 (4):1289-301. doi:\u00a010.1016\/j.neuroimage.2010.05.049<\/a>. PubMed\u00a0PMID:20570617<\/a>\u00a0PubMed Central\u00a0PMC2910162<\/a>.<\/li>
                          5. Elmenhorst, D, Minuzzi, L, Aliaga, A, Rowley, J, Massarweh, G, Diksic, M\u00a0et al.<\/i>. In vivo and\u00a0in vitro<\/i>\u00a0validation of reference tissue models for the mGluR(5) ligand [(11)C]ABP688. J Cereb Blood Flow Metab. 2010;30 (8):1538-49. doi:\u00a010.1038\/jcbfm.2010.65<\/a>. PubMed\u00a0PMID:20531460<\/a>\u00a0PubMed Central\u00a0PMC2949244<\/a>.<\/li>
                          6. Bellec, P,\u00a0Rosa-Neto, P<\/strong>, Lyttelton, OC, Benali, H, Evans, AC. Multi-level bootstrap analysis of stable clusters in resting-state fMRI. Neuroimage. 2010;51 (3):1126-39. doi:\u00a010.1016\/j.neuroimage.2010.02.082<\/a>. PubMed\u00a0PMID:20226257<\/a>\u00a0.<\/li>
                          7. la Foug\u00e8re, C, B\u00f6ning, G, Bartmann, H, W\u00e4ngler, B, Nowak, S, Just, T\u00a0et al.<\/i>. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar. Neuroimage. 2010;49 (2):1406-15. doi:\u00a010.1016\/j.neuroimage.2009.09.048<\/a>. PubMed\u00a0PMID:19796699<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                            \n\t\t\t\t
                            \n\t\t\t\t\t

                            2009<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                            \n\t\t\t\t
                            \n\t\t\t\t\t\t\t\t\t
                            1. Gong, G,\u00a0Rosa-Neto, P<\/strong>, Carbonell, F, Chen, ZJ, He, Y, Evans, AC\u00a0et al.<\/i>. Age- and gender-related differences in the cortical anatomical network. J Neurosci. 2009;29 (50):15684-93. doi:\u00a010.1523\/JNEUROSCI.2308-09.2009<\/a>. PubMed\u00a0PMID:20016083<\/a>\u00a0PubMed Central\u00a0PMC2831804<\/a>.<\/li>
                            2. Massarweh, G, Kovacevic, M,\u00a0Rosa-Neto, P<\/strong>, Evans, AC, Diksic, M, Schirrmacher, R\u00a0et al.<\/i>. Time-efficient and convenient synthesis of [(18)F]altanserin for human PET imaging by a new work-up procedure. Appl Radiat Isot. 2009;67 (11):2040-3. doi:\u00a010.1016\/j.apradiso.2009.07.020<\/a>. PubMed\u00a0PMID:19692252<\/a>\u00a0.<\/li>
                            3. Chakravarty, MM, Broadbent, S,\u00a0Rosa-Neto, P<\/strong>, Lambert, CM, Collins, DL. Design, construction, and validation of an MRI-compatible vibrotactile stimulator intended for clinical use. J Neurosci Methods. 2009;184 (1):129-35. doi:\u00a010.1016\/j.jneumeth.2009.07.018<\/a>. PubMed\u00a0PMID:19631690<\/a>\u00a0.<\/li>
                            4. Rosa-Neto, P<\/strong>, W\u00e4ngler, B, Iovkova, L, Boening, G, Reader, A, Jurkschat, K\u00a0et al.<\/i>. [18F]SiFA-isothiocyanate: a new highly effective radioactive labeling agent for lysine-containing proteins. Chembiochem. 2009;10 (8):1321-4. doi:\u00a010.1002\/cbic.200900132<\/a>. PubMed\u00a0PMID:19422010<\/a>\u00a0.<\/li>
                            5. Oishi, K, Faria, A, Jiang, H, Li, X, Akhter, K, Zhang, J\u00a0et al.<\/i>. Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer’s disease participants. Neuroimage. 2009;46 (2):486-99. doi:\u00a010.1016\/j.neuroimage.2009.01.002<\/a>. PubMed\u00a0PMID:19385016<\/a>\u00a0PubMed Central\u00a0PMC2885858<\/a>.<\/li>
                            6. Aznavour, N, Benkelfat, C, Gravel, P, Aliaga, A,\u00a0Rosa-Neto, P<\/strong>, Bedell, B\u00a0et al.<\/i>. MicroPET imaging of 5-HT 1A receptors in rat brain: a test-retest [18F]MPPF study. Eur J Nucl Med Mol Imaging. 2009;36 (1):53-62. doi:\u00a010.1007\/s00259-008-0891-1<\/a>. PubMed\u00a0PMID:18704404<\/a>\u00a0.<\/li>
                            7. Chakravarty, MM,\u00a0Rosa-Neto, P<\/strong>, Broadbent, S, Evans, AC, Collins, DL. Robust S1, S2, and thalamic activations in individual subjects with vibrotactile stimulation at 1.5 and 3.0 T. Hum Brain Mapp. 2009;30 (4):1328-37. doi:\u00a010.1002\/hbm.20598<\/a>. PubMed\u00a0PMID:18537113<\/a>\u00a0PubMed Central\u00a0PMC6871248<\/a>.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                              \n\t\t\t\t
                              \n\t\t\t\t\t

                              2008<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                              \n\t\t\t\t
                              \n\t\t\t\t\t\t\t\t\t
                              1. Nicolakakis, N, Aboulkassim, T, Ongali, B, Lecrux, C, Fernandes, P,\u00a0Rosa-Neto, P<\/strong>\u00a0et al.<\/i>. Complete rescue of cerebrovascular function in aged Alzheimer’s disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist. J Neurosci. 2008;28 (37):9287-96. doi:\u00a010.1523\/JNEUROSCI.3348-08.2008<\/a>. PubMed\u00a0PMID:18784309<\/a>\u00a0PubMed Central\u00a0PMC6670922<\/a>.<\/li>
                              2. Oishi, K, Zilles, K, Amunts, K, Faria, A, Jiang, H, Li, X\u00a0et al.<\/i>. Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter. Neuroimage. 2008;43 (3):447-57. doi:\u00a010.1016\/j.neuroimage.2008.07.009<\/a>. PubMed\u00a0PMID:18692144<\/a>\u00a0PubMed Central\u00a0PMC2586008<\/a>.<\/li>
                              3. Frey, BN,\u00a0Rosa-Neto, P<\/strong>, Lubarsky, S, Diksic, M. Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study. Neuroimage. 2008;42 (2):850-7. doi:\u00a010.1016\/j.neuroimage.2008.05.009<\/a>. PubMed\u00a0PMID:18583156<\/a>\u00a0.<\/li>
                              4. Chen, ZJ, He, Y,\u00a0Rosa-Neto, P<\/strong>, Germann, J, Evans, AC. Revealing modular architecture of human brain structural networks by using cortical thickness from MRI. Cereb Cortex. 2008;18 (10):2374-81. doi:\u00a010.1093\/cercor\/bhn003<\/a>. PubMed\u00a0PMID:18267952<\/a>\u00a0PubMed Central\u00a0PMC2733312<\/a>.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                \n\t\t\t\t
                                \n\t\t\t\t\t

                                2007<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                \n\t\t\t\t
                                \n\t\t\t\t\t\t\t\t\t
                                1. Rosa-Neto, P<\/strong>, Benkelfat, C, Sakai, Y, Leyton, M, Morais, JA, Diksic, M\u00a0et al.<\/i>. Brain regional alpha-[11C]methyl-L-tryptophan trapping, used as an index of 5-HT synthesis, in healthy adults: absence of an age effect. Eur J Nucl Med Mol Imaging. 2007;34 (8):1254-64. doi:\u00a010.1007\/s00259-007-0365-x<\/a>. PubMed\u00a0PMID:17318550<\/a>\u00a0.<\/li>
                                2. Pedersen, K, Simonsen, M, \u00d8stergaard, SD, Munk, OL,\u00a0Rosa-Neto, P<\/strong>, Olsen, AK\u00a0et al.<\/i>. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition. Neuroimage. 2007;35 (1):38-46. doi:\u00a010.1016\/j.neuroimage.2006.11.038<\/a>. PubMed\u00a0PMID:17223363<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                  \n\t\t\t\t
                                  \n\t\t\t\t\t

                                  2006<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                  \n\t\t\t\t
                                  \n\t\t\t\t\t\t\t\t\t
                                  1. Doudet, DJ,\u00a0Rosa-Neto, P<\/strong>, Munk, OL, Ruth, TJ, Jivan, S, Cumming, P\u00a0et al.<\/i>. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study. Neuroimage. 2006;30 (1):26-35. doi:\u00a010.1016\/j.neuroimage.2005.09.044<\/a>. PubMed\u00a0PMID:16378735<\/a>\u00a0.<\/li>
                                  2. Leyton, M, Paquette, V, Gravel, P,\u00a0Rosa-Neto, P<\/strong>, Weston, F, Diksic, M\u00a0et al.<\/i>. alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters. Eur Neuropsychopharmacol. 2006;16 (3):220-3. doi:\u00a010.1016\/j.euroneuro.2005.09.006<\/a>. PubMed\u00a0PMID:16269239<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                    \n\t\t\t\t
                                    \n\t\t\t\t\t

                                    2005<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                    \n\t\t\t\t
                                    \n\t\t\t\t\t\t\t\t\t
                                    1. Rosa-Neto, P<\/strong>, Diksic, M, Leyton, M, Mzengeza, S, Benkelfat, C. Stability of alpha-[11C]methyl-L-tryptophan brain trapping in healthy male volunteers. Eur J Nucl Med Mol Imaging. 2005;32 (10):1199-204. doi:\u00a010.1007\/s00259-005-1829-5<\/a>. PubMed\u00a0PMID:15948006<\/a>\u00a0.<\/li>
                                    2. Rosa-Neto, P<\/strong>, Lou, HC, Cumming, P, Pryds, O, Karrebaek, H, Lunding, J\u00a0et al.<\/i>. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage. 2005;25 (3):868-76. doi:\u00a010.1016\/j.neuroimage.2004.11.031<\/a>. PubMed\u00a0PMID:15808987<\/a>\u00a0.<\/li>
                                    3. Gjedde, A, Wong, DF,\u00a0Rosa-Neto, P<\/strong>, Cumming, P. Mapping neuroreceptors at work: on the definition and interpretation of binding potentials after 20 years of progress. Int Rev Neurobiol. 2005;63 :1-20. doi:\u00a010.1016\/S0074-7742(05)63001-2<\/a>. PubMed\u00a0PMID:15797463<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                      \n\t\t\t\t
                                      \n\t\t\t\t\t

                                      2004<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                      \n\t\t\t\t
                                      \n\t\t\t\t\t\t\t\t\t
                                      1. Rosa-Neto, P<\/strong>, Gjedde, A, Olsen, AK, Jensen, SB, Munk, OL, Watanabe, H\u00a0et al.<\/i>. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain. Synapse. 2004;53 (4):222-33. doi:\u00a010.1002\/syn.20053<\/a>. PubMed\u00a0PMID:15266554<\/a>\u00a0.<\/li>
                                      2. Rosa-Neto, P<\/strong>, Olsen, AK, Gjedde, A, Watanabe, H, Cumming, P. MDMA-evoked changes in cerebral blood flow in living porcine brain: correlation with hyperthermia. Synapse. 2004;53 (4):214-21. doi:\u00a010.1002\/syn.20052<\/a>. PubMed\u00a0PMID:15266553<\/a>\u00a0.<\/li>
                                      3. Rosa-Neto, P<\/strong>, Doudet, DJ, Cumming, P. Gradients of dopamine D1- and D2\/3-binding sites in the basal ganglia of pig and monkey measured by PET. Neuroimage. 2004;22 (3):1076-83. doi:\u00a010.1016\/j.neuroimage.2004.03.004<\/a>. PubMed\u00a0PMID:15219579<\/a>\u00a0.<\/li>
                                      4. Rosa-Neto, P<\/strong>, Diksic, M, Okazawa, H, Leyton, M, Ghadirian, N, Mzengeza, S\u00a0et al.<\/i>. Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch Gen Psychiatry. 2004;61 (6):556-63. doi:\u00a010.1001\/archpsyc.61.6.556<\/a>. PubMed\u00a0PMID:15184235<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                        \n\t\t\t\t
                                        \n\t\t\t\t\t

                                        2003<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                        \n\t\t\t\t
                                        \n\t\t\t\t\t\t\t\t\t
                                        1. Cumming, P,\u00a0Rosa-Neto, P<\/strong>, Watanabe, H, Smith, D, Bender, D, Clarke, PB\u00a0et al.<\/i>. Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain. Neuroimage. 2003;19 (3):1127-36. doi:\u00a010.1016\/s1053-8119(03)00079-x<\/a>. PubMed\u00a0PMID:12880838<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                          \n\t\t\t\t
                                          \n\t\t\t\t\t

                                          2002<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                          \n\t\t\t\t
                                          \n\t\t\t\t\t\t\t\t\t
                                          1. Rosa Neto, P, Lou, H, Cumming, P, Pryds, O, Gjedde, A. Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit. Ann N Y Acad Sci. 2002;965 :434-9. doi:\u00a010.1111\/j.1749-6632.2002.tb04184.x<\/a>. PubMed\u00a0PMID:12105118<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                            \n\t\t\t\t
                                            \n\t\t\t\t\t

                                            2001<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                            \n\t\t\t\t
                                            \n\t\t\t\t\t\t\t\t\t
                                            1. Bernasconi, A, Martinez, V,\u00a0Rosa-Neto, P<\/strong>, D’Agostino, D, Bernasconi, N, Berkovic, S\u00a0et al.<\/i>. Surgical resection for intractable epilepsy in “double cortex” syndrome yields inadequate results. Epilepsia. 2001;42 (9):1124-9. doi:\u00a010.1046\/j.1528-1157.2001.39900.x<\/a>. PubMed\u00a0PMID:11580758<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                              \n\t\t\t\t
                                              \n\t\t\t\t\t

                                              1997<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                              \n\t\t\t\t
                                              \n\t\t\t\t\t\t\t\t\t
                                              1. Lopes-Cendes, I, Teive, HG, Calcagnotto, ME, Da Costa, JC, Cardoso, F, Viana, E\u00a0et al.<\/i>. Frequency of the different mutations causing spinocerebellar ataxia (SCA1, SCA2, MJD\/SCA3 and DRPLA) in a large group of Brazilian patients. Arq Neuropsiquiatr. 1997;55 (3B):519-29. doi:\u00a010.1590\/s0004-282×1997000400001<\/a>. PubMed\u00a0PMID:9629399<\/a>\u00a0.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

                                                2022 Nilsson, J, Ashton, NJ, Benedet, AL, Montoliu-Gaya, L, Gobom, J, Pascoal, TA\u00a0et al.. Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease. Alzheimers Res Ther. 2022;14 (1):78. doi:\u00a010.1186\/s13195-022-01021-8. PubMed\u00a0PMID:35659284\u00a0. Karikari, TK, Ashton, NJ, Brinkmalm, G, Brum, WS, Benedet, AL, Montoliu-Gaya, L\u00a0et al.. Blood phospho-tau in Alzheimer disease: analysis, interpretation, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-325","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/tnl-mcgill.com\/index.php?rest_route=\/wp\/v2\/pages\/325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tnl-mcgill.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/tnl-mcgill.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/tnl-mcgill.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tnl-mcgill.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=325"}],"version-history":[{"count":40,"href":"https:\/\/tnl-mcgill.com\/index.php?rest_route=\/wp\/v2\/pages\/325\/revisions"}],"predecessor-version":[{"id":373,"href":"https:\/\/tnl-mcgill.com\/index.php?rest_route=\/wp\/v2\/pages\/325\/revisions\/373"}],"wp:attachment":[{"href":"https:\/\/tnl-mcgill.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}